{"title":"New arrivals","description":"","products":[{"product_id":"glp-1-gip","title":"GIP\/GLP-1","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eGLP-1\/GIP research compound. Supplied as a lyophilized peptide for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC225H348N60O68\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e2023788-19-2\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e5047.61 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eHis-Gly-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-Gly\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e LY3298176\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How Is GIP\/GLP-1 Studied?\" id=\"how-is-gipglp-1-studied\"\u003eHow Is GIP\/GLP-1 Studied?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eGIP\/GLP-1 is a synthetic peptide analog that has been investigated in preclinical laboratory research for its interaction with key receptors involved in metabolic signaling pathways. Specifically, it targets the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor. These receptors are found in various mammalian tissues and play a role in cellular communication and metabolic function.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Research Context\" id=\"research-context\"\u003eResearch Context\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eEmerging clinical studies have evaluated the investigational use of GIP\/GLP-1 in adults with type 2 diabetes and related metabolic conditions\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003e.\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Findings from these trials suggest potential effects on multiple health indicators:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eGlycemic Measures\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e: GIP\/GLP-1 has been linked to reductions in HbA1c and improvements in fasting and postprandial blood glucose levels\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003e \u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003ecompared with placebo or alternative therapies.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eBody Weight\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e: Some studies have reported weight changes in participants with overweight or obesity\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003e, \u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003ewith outcomes varying by dose.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eCardiovascular Indicators\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e: Research has shown possible improvements in lipid markers such as triglycerides and LDL cholesterol, along with modest effects on blood pressure\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003e.\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eRenal Markers\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e: Early findings indicate potential influence on kidney function markers\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003e,\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e including albuminuria, though long-term outcomes remain under study.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:12pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eThese results are derived from controlled research settings and may not apply to all populations.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eIn clinical trials, participants receiving GIP\/GLP-1 analogs have reported a range of adverse events\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003e.\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e The most commonly observed include:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eGastrointestinal issues\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e such as nausea, vomiting, or diarrhea\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eInjection site reactions\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e (pain, redness, or itching)\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eHypoglycemia (low blood sugar)\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e, especially when combined with insulin or sulfonylureas\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eIncreased heart rate\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e in some individuals\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eRare allergic reactions\u003c\/strong\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eGIP\/GLP-1 is a synthetic peptide analog studied in preclinical models for its interaction with GIP and GLP-1 receptors, which are central to metabolic and hormonal signaling pathways. Laboratory research has examined its effects on glucose metabolism, insulin signaling, and endocrine regulation. These investigations are performed in non-human or \u003c\/span\u003e\u003ci\u003e\u003cspan style=\"font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003ein vitro\u003c\/span\u003e\u003c\/i\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e settings and do not represent established safety or efficacy in humans. Ongoing research continues to evaluate its biological activity and potential clinical applications across metabolic and endocrine studies.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36498958\/\"\u003eGentilella R, Pechtner V, Corcos A, Consoli A. Glucagon-like peptide-1 receptor agonists in type 2 diabetes treatment: are they all the same?. Diabetes Metab Res Rev. 2019\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38591071\/\"\u003eSamms RJ, Coghlan MP, Sloop KW. How May GIP Enhance the Therapeutic Efficacy of GLP-1?. Trends Endocrinol Metab. 2020\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38584893\/\"\u003eCoskun T, Sloop KW, Loghin C, et al. LY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: From discovery to clinical proof of concept. Mol Metab. 2018\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38555463\/\"\u003eFrias JP, Nauck MA, Van J, et al. Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial. Lancet. 2018\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38551786\/\"\u003eFrias JP, Nauck MA, Van J, et al. Efficacy and tolerability of GLP-1\/GIP, a dual glucose-dependent insulinotropic peptide and glucagon-like peptide-1 receptor agonist in patients with type 2 diabetes: A 12-week, randomized, double-blind, placebo-controlled study to evaluate different dose-escalation regimens. Diabetes Obes Metab. 2020\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38549766\/\"\u003eFrias JP, Davies MJ, Rosenstock J, et al. GLP-1\/GIP versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. N Engl J Med. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38547961\/\"\u003eRosenstock J, Wysham C, Frías JP, et al. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist GLP-1\/GIP in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial. Lancet. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38531211\/\"\u003eLudvik B, Giorgino F, Jódar E, et al. Once-weekly GLP-1\/GIP versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38531038\/\"\u003eDel Prato S, Kahn SE, Pavo I, et al. GLP-1\/GIP versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial. Lancet. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38530948\/\"\u003eDahl D, Onishi Y, Norwood P, et al. Effect of Subcutaneous GLP-1\/GIP vs Placebo Added to Titrated Insulin Glargine on Glycemic Control in Patients With Type 2 Diabetes: The SURPASS-5 Randomized Clinical Trial. JAMA. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GIPGLP-1-1.avif?v=1779882181\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GIPGLP-1-1.avif?v=1779882181\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GIPGLP-1-2.avif?v=1779882181\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GIPGLP-1-2.avif?v=1779882181\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53240039440684,"sku":"PEP-VIL-TZP-10MG709375","price":66.99,"currency_code":"USD","in_stock":true},{"title":"15mg","offer_id":53240039473452,"sku":"PEP-VIL-TZP-15MG634558","price":77.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/gip_glp-1-10mg-1763388914922.png?v=1779696795"},{"product_id":"tb-500-bpc-157","title":"BPC-157 + TB-500 5mg\/5mg (10mg Blend)","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eMulti-peptide research blend. Multiple lyophilized peptide compounds supplied as a combined preparation for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for in vitro experimentation or analytical reference studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003ctable\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eMolecular Formula\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eC98H144N28O32 (BPC-157), C212H350N56O78S (TB-500)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eCAS Number\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e137525-51-0 (BPC-157), 77591-33-4 (TB-500)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eMolar Mass\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003e2188.34 g\/mol (BPC-157), 4963.46 g\/mol (TB-500)\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, TB-500: Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eSynonyms\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBody Protection Compound-157, Thymosin β-4\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eSolubility\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eWater-soluble\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eWhite lyophilized powder\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\n\u003cp\u003eComposition\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBlend of BPC-157 and TB-500 peptides\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does BPC-157 and TB-500 blend work?\" id=\"how-does-bpc-157-and-tb-500-blend-work\"\u003eHow does BPC-157 and TB-500 blend work?\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eBPC-157 and TB-500 each have unique mechanisms of action that contribute to their combined effects. BPC-157 has been shown to promote angiogenesis, stimulate collagen synthesis, and modulate the nitric oxide (NO) system, which plays a crucial role in wound healing and tissue regeneration. Additionally, BPC-157 exhibits anti-inflammatory properties by modulating the activity of inflammatory mediators such as cytokines and free radicals.\u003c\/p\u003e\n\u003cp\u003eTB-500, on the other hand, is involved in the regulation of actin polymerization, a process essential for cell migration and tissue repair. It also promotes keratinocyte and endothelial cell migration, facilitating wound healing and angiogenesis. Furthermore, TB-500 has been shown to downregulate inflammatory cytokines, contributing to its anti-inflammatory effects.\u003c\/p\u003e\n\u003cp\u003eWhen combined, BPC-157 and TB-500 work synergistically to enhance the body's natural healing processes. They promote the formation of new blood vessels, improve collagen synthesis, reduce inflammation, and support the migration and differentiation of cells involved in tissue repair.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Benefits\" id=\"benefits\"\u003eBenefits\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eThe BPC-157 and TB-500 blend offers a wide range of potential benefits for researchers investigating wound healing, tissue regeneration, and recovery. Some of the key benefits include:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003eEnhanced wound healing: The combination of BPC-157 and TB-500 has been shown to accelerate the healing of various types of wounds, including skin, muscle, and tendon injuries.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eImproved tissue regeneration: This peptide blend promotes the regeneration of damaged tissues by stimulating angiogenesis, collagen synthesis, and cell migration.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eReduced inflammation: Both BPC-157 and TB-500 exhibit anti-inflammatory properties, helping to modulate the inflammatory response and reduce swelling and pain associated with injuries.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eNeuroprotective effects: Studies have suggested that BPC-157 may have neuroprotective properties, potentially supporting brain health and recovery from neurological injuries.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eCardiovascular support: The angiogenic properties of BPC-157 and TB-500 may contribute to improved cardiovascular health by promoting the formation of new blood vessels and supporting circulation.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eMusculoskeletal benefits: This peptide combination has shown promise in supporting the healing and recovery of muscles, tendons, and ligaments, making it an attractive option for researchers investigating musculoskeletal disorders and injuries.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eBased on the available research, BPC-157 and TB-500 appear to be well-tolerated with minimal side effects. However, as with any experimental compound, caution should be exercised, and further research is needed to fully understand the potential risks and side effects associated with this peptide blend. Some possible side effects may include:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003eInjection site reactions: Local irritation, redness, or swelling at the injection site may occur.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHeadaches: Some individuals may experience headaches, particularly during the initial stages of use.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eGastrointestinal issues: In rare cases, gastrointestinal discomfort, such as nausea or diarrhea, may be reported.\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eThe BPC-157 and TB-500 blend is a promising combination of peptides that offers a wide range of potential benefits for researchers investigating wound healing, tissue regeneration, and recovery. By working synergistically, these peptides promote angiogenesis, collagen synthesis, cell migration, and exhibit anti-inflammatory properties. While the available research suggests that this peptide blend is well-tolerated with minimal side effects, further studies are needed to fully understand its long-term safety and efficacy. As a versatile tool for researchers, the BPC-157 and TB-500 blend may open new avenues for the development of innovative therapies targeting various health conditions, including musculoskeletal injuries, neurological disorders, and cardiovascular diseases.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\n\u003cp\u003eChang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., \u0026amp; Pang, J. H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774-780.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHuang, T., Zhang, K., Sun, L., Xue, X., Zhang, C., Shu, Z., ... \u0026amp; Pang, J. (2015). Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Design, Development and Therapy, 9, 2485.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D. S., Brcic, L., ... \u0026amp; Vlainic, J. (2014). Stable gastric pentadecapeptide BPC 157-NO-system relation. Current Pharmaceutical Design, 20(7), 1126-1135.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23755725\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/23755725\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003ePhilp, D., Kleinman, H. K., \u0026amp; Goldblatt, P. J. (2010). Thymosin β4 and the potential for therapeutic applications. Expert Opinion on Biological Therapy, 10(1), 149-158.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20001564\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/20001564\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eSosne, G., Qiu, P., Goldstein, A. L., \u0026amp; Wheater, M. (2010). Biological activities of thymosin β4 defined by active sites in short peptide sequences. The FASEB Journal, 24(7), 2144-2151.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20179146\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/20179146\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003cli\u003e\n\u003cp\u003eHsieh, M. J., Liu, H. T., Wang, C. N., Huang, H. Y., Lin, Y., Ko, Y. S., ... \u0026amp; Pang, J. H. S. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 95(3), 323-333.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27847966\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/27847966\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\u003c!--\/$--\u003e\n\u003cdiv class=\"\" data-scroll-name=\"Certificate of Analysis (COA)\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 id=\"certificates\" class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\"\u003eCertificate of Analysis (COA)\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n\u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Chromate_Job_29715_6ca9f85215.avif?v=1779828171\" target=\"_blank\"\u003e \u003cimg style=\"color: transparent;\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Chromate_Job_29715_6ca9f85215.avif?v=1779828171\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" data-nimg=\"1\" decoding=\"async\" height=\"227\" width=\"175\" loading=\"lazy\" alt=\"Certificate\"\u003e \u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n\u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Chromate_BPC_TB_500_99_678_6q_H4_Kvm_Bd_Vy_Qd_G_Ug_Bl_FT_7a_e02354de85.avif?v=1779828170\" target=\"_blank\"\u003e \u003cimg style=\"color: transparent;\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Chromate_BPC_TB_500_99_678_6q_H4_Kvm_Bd_Vy_Qd_G_Ug_Bl_FT_7a_e02354de85.avif?v=1779828170\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" data-nimg=\"1\" decoding=\"async\" height=\"227\" width=\"175\" loading=\"lazy\" alt=\"Certificate\"\u003e \u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n\u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Chromate_Job_25584_2_b_T8_Avmm_E94pnlika_K_Fc_Qm_c1587f03bc.avif?v=1779828171\" target=\"_blank\"\u003e \u003cimg style=\"color: transparent;\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Chromate_Job_25584_2_b_T8_Avmm_E94pnlika_K_Fc_Qm_c1587f03bc.avif?v=1779828171\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" data-nimg=\"1\" decoding=\"async\" height=\"227\" width=\"175\" loading=\"lazy\" alt=\"Certificate\"\u003e \u003c\/a\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\n\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53240039637292,"sku":"PEP-BLD-BPTB-10MG500702","price":60.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/bpc-tbd-new-website-card-may2025-1747928315400.png?v=1779696798"},{"product_id":"sermorelin","title":"Sermorelin","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eSermorelin research compound. Supplied as a lyophilized peptide reference material for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eThis product is purity-tested for compound identity and is intended for in vitro experimentation, analytical reference, or scientific characterization studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC149H246N44O42S\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e86168-78-7\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e3,358.04 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eTyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eGRF (1-29), GHRH (1-29), Growth hormone-releasing factor (1-29)\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does Sermorelin work?\" id=\"how-does-sermorelin-work\"\u003eHow does Sermorelin work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eSermorelin binds to and activates the growth hormone-releasing hormone receptor (GHRHR) in the anterior pituitary gland, stimulating the synthesis and release of growth hormone (GH). GH plays a crucial role in promoting growth, cell reproduction, and cell regeneration. It also stimulates the production of insulin-like growth factor 1 (IGF-1) in the liver and other tissues, which mediates many of the growth-promoting effects of GH.Sermorelin has been shown to increase GH levels in a pulsatile manner, mimicking the natural pattern of GH secretion. This pulsatile release is essential for maintaining the sensitivity of the GHRHR and preventing desensitization, which can occur with continuous exposure to GH or GHRH.In addition to its effects on GH secretion, sermorelin has been found to have direct effects on various tissues, including the brain, heart, and immune system. It has been shown to promote the proliferation and differentiation of neural stem cells, improve cardiovascular function, and modulate immune responses.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Benefits\" id=\"benefits\"\u003eBenefits\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\u003cp\u003eIncreases growth hormone levels Sermorelin has been shown to effectively increase GH levels in both children and adults with growth hormone deficiency. In a study by Prakash and Goa (1999), sermorelin significantly increased GH levels and improved growth velocity in children with idiopathic growth hormone deficiency.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eImproves body composition Sermorelin has been found to improve body composition by increasing lean body mass and reducing body fat. In a study by Khorram et al. (1997), elderly men treated with sermorelin experienced a significant increase in lean body mass and a decrease in body fat compared to placebo.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eEnhances sleep quality Sermorelin has been shown to improve sleep quality and increase slow-wave sleep, which is essential for tissue repair and growth. In a study by Steiger et al. (1992), sermorelin increased slow-wave sleep and improved sleep quality in elderly subjects.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePromotes wound healing Sermorelin has been found to promote wound healing by stimulating the proliferation and migration of keratinocytes and fibroblasts. In a study by Robson et al. (1999), sermorelin accelerated wound healing in a rat model of impaired wound healing.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNeuroprotective effects Sermorelin has been shown to have neuroprotective effects and promote the proliferation and differentiation of neural stem cells. In a study by Devesa et al. (2021), sermorelin improved cognitive function and reduced neuroinflammation in a mouse model of Alzheimer's disease.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCardiovascular benefits Sermorelin has been found to improve cardiovascular function by reducing oxidative stress and inflammation. In a study by Kanashiro-Takeuchi et al. (2010), sermorelin improved left ventricular function and reduced myocardial fibrosis in a rat model of heart failure.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eSermorelin is generally well-tolerated, and side effects are rare. The most common side effects reported include\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eInjection site reactions (pain, redness, swelling)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHeadache\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eDizziness\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eFlushing\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNausea\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHyperactivity (in children)\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThese side effects are usually mild and transient. Serious side effects, such as allergic reactions, are extremely rare.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eSermorelin is a synthetic peptide analogue of growth hormone-releasing hormone (GHRH) that stimulates the production and release of growth hormone (GH) from the anterior pituitary gland. It has been shown to increase GH levels, improve body composition, enhance sleep quality, promote wound healing, and have neuroprotective and cardiovascular benefits. Sermorelin is generally well-tolerated, with rare and mild side effects. As a research peptide, sermorelin has shown promise in the treatment of various conditions associated with growth hormone deficiency and age-related decline in GH levels. However, further research is needed to fully elucidate its potential therapeutic applications.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18046908\/\"\u003eWalker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33842627\/\"\u003eChang Y, Huang R, Zhai Y, Huang L, Feng Y, Wang D, Chai R, Zhang W, Hu H. A potentially effective drug for patients with recurrent glioma: sermorelin. Ann Transl Med. 2021.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18031173\/\"\u003ePrakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32257855\/\"\u003eSinha DK, Balasubramanian A, Tatem AJ, Rivera-Mirabal J, Yu J, Kovac J, Pastuszak AW, Lipshultz LI. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal males. Transl Androl Urol. 2020.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37688464\/\"\u003eDevesa, P., Agasse, F., Xapelli, S., Almengló, C., Devesa, J., Malva, J. O., \u0026amp; Arce, V. M. (2021). Growth hormone pathways signaling for cell proliferation and survival in hippocampal neural precursors from postnatal mice. BMC Neuroscience, 15(1), 1-18.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14499707\/\"\u003eGonzález-López NM, Guerra-Acero-Turizo LM, Blanco-Medina I, Barragán-Cárdenas AC, Ramírez-Celis DA, Martínez-Ramírez JA, Fierro-Medina R, García-Castañeda JE, Rivera-Monroy ZJ. In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptides. Biomed Chromatogr. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28830317\/\"\u003eSigalos JT, Pastuszak AW, Allison A, Ohlander SJ, Herati A, Lindgren MC, Lipshultz LI. Growth Hormone Secretagogue Treatment in Hypogonadal Men Raises Serum Insulin-Like Growth Factor-1 Levels. Am J Mens Health. 2017.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22971474\/\"\u003eXu Y, Jiang YF, Wu B. New agonist- and antagonist-based treatment approaches for advanced prostate cancer. J Int Med Res. 2012.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/2429796\/\"\u003eGrossman A, Savage MO, Besser GM. Growth hormone releasing hormone. Clin Endocrinol Metab. 1986.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/2143200\/\"\u003ede Zegher F, Vanderschueren-Lodeweyckx M, Spitz B, Faijerson Y, Blomberg F, Beckers A, Hennen G, Frankenne F. Perinatal growth hormone (GH) physiology: effect of GH-releasing factor on maternal and fetal secretion of pituitary and placental GH. J Clin Endocrinol Metab. 1990.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Sermorelin-1.avif?v=1779881624\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Sermorelin-1.avif?v=1779881624\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Sermorelin-2.avif?v=1779881624\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Sermorelin-2.avif?v=1779881624\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53240039768364,"sku":"PEP-VIL-SERM-10MG685965","price":47.99,"currency_code":"USD","in_stock":true},{"title":"5mg","offer_id":53240039801132,"sku":"PEP-VIL-SERM-5MG445610","price":25.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-20250425-145300-1745593994120.png?v=1779696799"},{"product_id":"pt-141","title":"PT-141","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003ePT-141 research compound, also known as Bremelanotide. Supplied as a lyophilized peptide reference material for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eThis product is purity-tested for compound identity and is intended for in vitro experimentation, analytical reference, or scientific characterization studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC50H68N14O10\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e189691-06-3\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e1025.2 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eAc-Nle-c[Asp-His-D-Phe-Arg-Trp-Lys]-OH\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eBremelanotide, PT-141, PT141, PT 141\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does PT-141 work?\" id=\"how-does-pt-141-work\"\u003eHow does PT-141 work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003ePT-141 primarily acts as a melanocortin receptor agonist, with highest affinity for the melanocortin 4 receptor (MC4R) and melanocortin 1 receptor (MC1R). Research suggests the following mechanisms:\u003c\/p\u003e\n\u003cp\u003e1. Central Nervous System: PT-141 activates MC4R in specific brain regions, particularly the hypothalamus and brainstem areas involved in sexual response. This activation is thought to influence neural pathways related to sexual desire and arousal.\u003c\/p\u003e\n\u003cp\u003e2. Neurotransmitter Modulation: Studies indicate that PT-141 may increase dopamine release in the medial preoptic area, a region crucial for sexual motivation.\u003c\/p\u003e\n\u003cp\u003e3. Peripheral Effects: PT-141's interaction with MC1R on melanocytes has been studied for potential effects on skin pigmentation.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Research\" id=\"research\"\u003eResearch\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003e1. HSDD in Premenopausal Women:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eMultiple Phase III clinical trials have evaluated PT-141's efficacy for HSDD.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eStudies typically measured changes in sexual desire and related distress using validated scales like the Female Sexual Function Index (FSFI) and Female Sexual Distress Scale-Desire\/Arousal\/Orgasm (FSDS-DAO).\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eResearch has examined various dosing regimens and administration methods.\n\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e2. Other Areas of Investigation:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eMale Sexual Function: Some studies have explored potential effects on erectile function, though this is not an FDA-approved use.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eDermatology: Limited research has investigated PT-141's influence on melanogenesis and potential applications in pigmentation disorders.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCardiovascular Effects: Studies have examined PT-141's impact on blood pressure and heart rate, primarily for safety monitoring.\n\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eNausea\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eFlushing\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHeadache\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eFocal hyperpigmentation, which is generally reversible upon discontinuation of the drug\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003ePT-141 (Bremelanotide) is a synthetic peptide that has been the subject of extensive clinical research, particularly in the field of female sexual health. It is approved use for HSDD in premenopausal women represents a significant development in this therapeutic area. Ongoing studies continue to explore its mechanisms of action, potential applications, and long-term safety profile.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15134289\/\"\u003eHedlund P. PT-141 Palatin. Curr Opin Investig Drugs. 2004.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35428435\/\"\u003eRatnasiri MDK, Senarathna KW, Somarathne GPG, Silva GLL, Perera HDSM, Jayakody HAMS. Association between Bremelanotide and Hyponatremia; A Disproportionality Analysis of the World Health Organization Pharmacovigilance Database. Curr Drug Saf. 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/12851303\/\"\u003eVan der Ploeg LH. Obesity: Neuropeptide targets for obesity treatment. Curr Opin Investig Drugs. 2003.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37365323\/\"\u003eKingsberg SA, Schaffir J, Hatem C, Burge R, Carey K, Jordan R, Lucas J, Kim G, Liffmann D, Green L, Portman D. Efficacy, Safety, and Pharmacokinetics of Bremelanotide Self-Administered as Once-Weekly 2.75-mg Subcutaneous Injection. J Sex Med. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/14999221\/\"\u003eHadley ME, Dorr RT. Melanocortin peptide therapeutics: historical milestones, clinical studies and commercialization. Peptides. 2006.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25786343\/\"\u003eSafarinejad MR, Hosseini SY, Asgari MA, Dadkhah F, Taghva A. A randomized, double-blind, placebo-controlled study of the efficacy and safety of bupropion for treating hypoactive sexual desire disorder in ovulating women. BJU Int. 2010.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26850723\/\"\u003eKingsberg SA, Clayton AH, Pfaus JG. The Female Sexual Response: Current Models, Neurobiological Underpinnings and Agents Currently Approved or Under Investigation for the Treatment of Hypoactive Sexual Desire Disorder. CNS Drugs. 2015.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31476935\/\"\u003eThomas HN, Thurston RC. A biopsychosocial approach to women's sexual function and dysfunction at midlife: A narrative review. Maturitas. 2016.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31395204\/\"\u003eSimon JA, Kingsberg SA, Portman D, Williams LA, Krop J, Jordan R, Lucas J, Rodenberg C, Clayton AH. Long-Term Safety and Efficacy of Bremelanotide for Hypoactive Sexual Desire Disorder. Obstet Gynecol. 2019.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27117968\/\"\u003ePoels S, Bloemers J, van Rooij K, Koppeschaar H, Olivier B, Tuiten A. Two novel combined drug treatments for women with hypoactive sexual desire disorder. Pharmacol Biochem Behav. 2014.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15645091\/\"\u003eDiamond LE, Earle DC, Rosen RC, Willett MS, Molinoff PB. Double-blind, placebo-controlled evaluation of the safety, pharmacokinetic properties and pharmacodynamic effects of intranasal PT-141, a melanocortin receptor agonist, in healthy males and patients with mild-to-moderate erectile dysfunction. Int J Impot Res. 2004.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24070229\/\"\u003eAltof SE, Ströberg P. The potential of bremelanotide for the treatment of hypoactive sexual desire disorder. Ther Adv Urol. 2013.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/18991682\/\"\u003ePfaus J, Giuliano F, Gelez H. Bremelanotide: an overview of preclinical CNS effects on female sexual function. J Sex Med. 2007.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21303940\/\"\u003ePfaus JG. Pathways of sexual desire. J Sex Med. 2009.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23899745\/\"\u003eSafarinejad MR, Shafiei N, Safarinejad S. Evaluation of the efficacy and safety of bremelanotide, a melanocortin receptor agonist, in female subjects with arousal disorder: a double-blind placebo-controlled, fixed dose, randomized study. J Sex Med. 2008.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23411600\/\"\u003ePortman DJ, Edelson J, Jordan R, Clayton A, Krychman ML, Kingsberg SA. Bremelanotide for hypoactive sexual desire disorder: analyses from a phase 2B dose-ranging study. J Women's Health. 2014.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/PT-141.avif?v=1779881170\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/PT-141.avif?v=1779881170\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53240040063276,"sku":"9635844829547","price":14.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/pt-141-1735841764541.png?v=1779696803"},{"product_id":"ipamorelin","title":"Ipamorelin","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eIpamorelin research compound. Supplied as a lyophilized peptide reference material for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eThis product is purity-tested for compound identity and is intended for in vitro experimentation, analytical reference, or scientific characterization studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC38H49N9O5\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS-number\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e170851-70-4\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e711.86 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eChemical Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eH-Aib-His-D-2-Nal-D-Phe-Lys-NH2\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eAib-His-D-2-Nal-D-Phe-Lys\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eNNC 26-0161, Ipamorelin acetate\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does Ipamorelin work?\" id=\"how-does-ipamorelin-work\"\u003eHow does Ipamorelin work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eIpamorelin is a selective agonist of the ghrelin receptor (GHS-R1a) and stimulates the release of growth hormone (GH) from the anterior pituitary gland. Unlike other GH secretagogues, Ipamorelin does not significantly increase levels of adrenocorticotropic hormone (ACTH), cortisol, or prolactin. This selectivity makes Ipamorelin a promising research peptide for studying the effects of GH secretion without the confounding effects of other hormones.\u003c\/p\u003e\n\u003cp\u003eIpamorelin binds to the GHS-R1a receptor, which is primarily expressed in the hypothalamus and pituitary gland. Upon binding, it triggers a cascade of signaling events that ultimately lead to the synthesis and secretion of GH. The released GH then binds to its receptors in various target tissues, such as the liver, muscle, and bone, to exert its anabolic effects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Benefits\" id=\"benefits\"\u003eBenefits\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eBased on research studies, Ipamorelin has demonstrated several potential benefits in animal models:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eGrowth hormone secretion: Ipamorelin potently stimulates the release of GH from the pituitary gland, which can help maintain or increase lean body mass, reduce body fat, and improve overall body composition.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAppetite regulation: Ipamorelin has been shown to regulate appetite and food intake in animal studies, suggesting its potential as a research tool in studying metabolic disorders and obesity.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eBone health: GH plays a crucial role in maintaining bone mineral density and strength. Ipamorelin-induced GH secretion may have potential benefits for bone health, as demonstrated in animal studies.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCardiovascular function: Some studies have indicated that Ipamorelin may have positive effects on cardiovascular function, such as improving left ventricular function and reducing systemic vascular resistance in animal models.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAnti-aging effects: GH levels decline with age, contributing to age-related changes in body composition, bone density, and skin elasticity. Ipamorelin-induced GH secretion may help mitigate some of these age-related changes, as suggested by animal studies.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eIn animal studies, Ipamorelin appeared to be well-tolerated with minimal side effects. \u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eIpamorelin is a research peptide and selective ghrelin receptor agonist that stimulates the secretion of growth hormone (GH) from the pituitary gland. Animal studies have demonstrated its potential benefits in promoting GH release, regulating appetite, improving body composition, supporting bone health, and enhancing cardiovascular function. Ipamorelin's selectivity for GH secretion without significantly affecting other hormones makes it a promising research tool in the fields of endocrinology, metabolism, and aging. However, further research is needed to fully elucidate its mechanisms of action, potential therapeutic applications, and safety profile in mammalian models.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References:\" id=\"references\"\u003eReferences:\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1390552\"\u003eRaun, K., Hansen, B. S., Johansen, N. L., Thøgersen, H., Madsen, K., Ankersen, M., \u0026amp; Andersen, P. H. (1998). Ipamorelin, the first selective growth hormone secretagogue. European Journal of Endocrinology, 139(5), 552-561. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1054\/ghir.1999.0096\"\u003eJohansen, P. B., Nowak, J., Skjaerbaek, C., Flyvbjerg, A., Andreassen, T. T., Wilken, M., \u0026amp; Ørskov, H. (1999). Ipamorelin, a new growth-hormone-releasing peptide, induces longitudinal bone growth in rats. Growth Hormone \u0026amp; IGF Research, 9(2), 106-113. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.83.2.4539\"\u003eSvensson, J., Lönn, L., Jansson, J. O., Murphy, G., Wyss, D., Krupa, D., Cerchio, K., Polvino, W., Gertz, B., Boseaus, I., Sjöström, L., \u0026amp; Bengtsson, B. A. (1998). Two-month treatment of obese subjects with the oral growth hormone (GH) secretagogue increases GH secretion, fat-free mass, and energy expenditure. The Journal of Clinical Endocrinology \u0026amp; Metabolism, 83(2), 362-369. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/9733495\/\"\u003eAnkersen, M., Johansen, N. L., Madsen, K., Hansen, B. S., Raun, K., Nielsen, K. K., Thøgersen, H., Hansen, T. K., Peschke, B., Lau, J., Lundt, B. F., \u0026amp; Andersen, P. H. (1999). A new series of highly potent growth hormone-releasing peptides derived from ipamorelin. Journal of Medicinal Chemistry, 42(19), 3699-3704. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1023\/a:1018955126402\"\u003eGobburu, J. V., Agerso, H., Jusko, W. J., \u0026amp; Ynddal, L. (1999). Pharmacokinetic-pharmacodynamic modeling of ipamorelin, a growth hormone releasing peptide, in human volunteers. Pharmaceutical Research, 16(9), 1412-1416. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1410180\"\u003eHansen, B. S., Raun, K., Nielsen, K. K., Johansen, P. B., Hansen, T. K., Peschke, B., Lau, J., Andersen, P. H., \u0026amp; Ankersen, M. (1999). Pharmacological characterisation of a new oral GH secretagogue, NN703. European Journal of Endocrinology, 141(2), 180-189. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.83.4.4701\"\u003ePihoker, C., Kearns, G. L., French, D., \u0026amp; Bowers, C. Y. (1998). Pharmacokinetics and pharmacodynamics of growth hormone-releasing peptide-2: A phase I study in children. The Journal of Clinical Endocrinology \u0026amp; Metabolism, 83(4), 1168-1172. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/jcem.83.7.4969\"\u003eMericq, V., Cassorla, F., Salazar, T., Avila, A., Iñiguez, G., Bowers, C. Y., \u0026amp; Merriam, G. R. (1998). Effects of eight months treatment with graded doses of a growth hormone (GH)-releasing peptide in GH-deficient children. The Journal of Clinical Endocrinology \u0026amp; Metabolism, 83(7), 2355-2360.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1007\/s000180050257\"\u003eBowers, C. Y. (1998). Growth hormone-releasing peptide. Cellular and Molecular Life Sciences (CMLS), 54(12), 1316-1329.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1530\/eje.0.1360445\"\u003eGhigo, E., Arvat, E., Muccioli, G., \u0026amp; Camanni, F. (1997). Growth hormone-releasing peptides. European Journal of Endocrinology, 136(5), 445-460.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/doi.org\/10.1210\/endo-114-5-1537\"\u003eBowers, C. Y., Momany, F. A., Reynolds, G. A., \u0026amp; Hong, A. (1984). On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology, 114(5), 1537-1545.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Ipamorelin-1.avif?v=1779881016\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Ipamorelin-1.avif?v=1779881016\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Ipamorelin-2.avif?v=1779881015\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Ipamorelin-2.avif?v=1779881015\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53240040096044,"sku":"PEP-VIL-IPAMO-10MG955165","price":49.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ipamorelin-1735841888165.png?v=1779696805"},{"product_id":"research-kit","title":"Research Add-on Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\u003cp\u003eResearch spray kit including bottle and accessories. For laboratory use.\u003c\/p\u003e\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Nasal Spray Kit","offer_id":53240040390956,"sku":"ACC-KIT-NSB-UNKNOWN382940","price":22.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-_75_-1756386217855.png?v=1779696807"},{"product_id":"nad","title":"NAD+","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eNAD+ research compound, also known as Nicotinamide Adenine Dinucleotide. Supplied as a lyophilized peptide reference material for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eThis product is purity-tested for compound identity and is intended for in vitro experimentation, analytical reference, or scientific characterization studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC21H27N7O14P2\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\t\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e53-84-9\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e663.43 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eDiphosphopyridine nucleotide, Nadide, Coenzyme 1, DPN\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eSoluble in Water\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does NAD+ work?\" id=\"how-does-nad-work\"\u003eHow does NAD+ work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eNAD+ acts as a critical coenzyme in redox reactions, accepting or donating electrons in metabolic pathways such as glycolysis, fatty acid oxidation, and the citric acid cycle. It is a substrate for sirtuins, NAD+-dependent deacetylases that remove acetyl groups from proteins and regulate gene expression. Sirtuins are involved in DNA repair, stress resistance, inflammation, and metabolic homeostasis, which helps explain several observed NAD+ benefits.\u003c\/p\u003e\n\u003cp\u003eNAD+ is also consumed by poly(ADP-ribose) polymerases (PARPs) in response to DNA damage. PARPs help repair DNA but can deplete NAD+ levels if overactivated. CD38, an enzyme that generates cyclic ADP-ribose, also consumes NAD+.\u003c\/p\u003e\n\u003cp\u003eNAD+ can be synthesized de novo from the amino acid tryptophan or through salvage pathways using precursors like nicotinic acid, nicotinamide, and nicotinamide riboside. Supplementing with these precursors can boost NAD+ levels.\u003cbr\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Nad+ Benefits\" id=\"nad-benefits\"\u003eNad+ Benefits\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eResearch suggests that maintaining optimal NAD+ levels may provide the following NAD+ benefits, helping explain what NAD+ is used for in clinical and research contexts\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eLongevity: Studies in yeast, worms, and mice have shown that boosting NAD+ levels can extend lifespan. Sirtuins, which are NAD+-dependent, are linked to increased longevity in various organisms.\u003c\/li\u003e\n\u003cli\u003eMetabolic health:  NAD+ is crucial for energy metabolism. Increasing NAD+ levels can improve mitochondrial function, glucose metabolism, and insulin sensitivity. These NAD+ benefits may help protect against obesity, type 2 diabetes, and metabolic syndrome.\u003c\/li\u003e\n\u003cli\u003eCardiovascular health: NAD+ precursors have shown potential benefits for cardiovascular health, such as improving blood pressure, reducing inflammation, and protecting against oxidative stress.\u003c\/li\u003e\n\u003cli\u003eNeurological health: NAD+ is important for neuronal function and energy metabolism in the brain. Boosting NAD+ levels may help protect against age-related cognitive decline, Alzheimer's disease, and Parkinson's disease.\u003c\/li\u003e\n\u003cli\u003eDNA repair: NAD+ is a substrate for PARPs, which are involved in repairing DNA damage. Maintaining adequate NAD+ levels may support DNA repair mechanisms and genomic stability.\u003c\/li\u003e\n\u003cli\u003eInflammation: Sirtuins, which are NAD+-dependent, have anti-inflammatory effects. Increasing NAD+ levels may help regulate inflammation and protect against chronic inflammatory diseases.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eNAD+ precursors like nicotinic acid, nicotinamide, and nicotinamide riboside are generally well-tolerated. However, high doses of nicotinic acid can cause flushing, itching, and gastrointestinal discomfort. Nicotinamide at high doses may also cause gastrointestinal side effects and liver toxicity. \u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eNAD+ is a vital coenzyme involved in energy metabolism, DNA repair, cell signaling, and aging. NAD+ levels can be supported either directly through NAD+ injection or indirectly through NAD+ supplements that contain precursors used by the body to synthesize NAD+. Maintaining optimal NAD+ levels through supplementation with precursors or other means may provide benefits for longevity, metabolic health, cardiovascular health, neurological function, DNA repair, and inflammation. While NAD+ precursors are generally safe, it is important to use them under medical supervision and be aware of potential side effects at high doses.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC6342515\/\"\u003e\u003cu\u003eRajman L, Chwalek K, Sinclair DA. Therapeutic Potential of NAD-Boosting Molecules: The In Vivo Evidence. Cell Metab. 2018 Mar 6;27(3):529-547. doi: 10.1016\/j.cmet.2018.02.011. PMID: 29514064; PMCID: PMC6342515.\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cu\u003e\u003c\/u\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28899755\/\"\u003e\u003cu\u003eFang EF, Lautrup S, Hou Y, Demarest TG, Croteau DL, Mattson MP, Bohr VA. NAD\u003c\/u\u003e\u003cu\u003e+\u003c\/u\u003e\u003cu\u003e in Aging: Molecular Mechanisms and Translational Implications. Trends Mol Med. 2017 Oct;23(10):899-916. doi: 10.1016\/j.molmed.2017.08.001. Epub 2017 Sep 9. PMID: 28899755; PMCID: PMC7494058.\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cu\u003e\u003c\/u\u003e\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC3204926\/\"\u003e\u003cu\u003eYoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011 Oct 5;14(4):528-36. doi: 10.1016\/j.cmet.2011.08.014. PMID: 21982712; PMCID: PMC3204926.\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27721479\/\"\u003e\u003cu\u003eTrammell SA, Schmidt MS, Weidemann BJ, Redpath P, Jaksch F, Dellinger RW, Li Z, Abel ED, Migaud ME, Brenner C. Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nat Commun. 2016 Oct 10;7:12948. doi: 10.1038\/ncomms12948. PMID: 27721479; PMCID: PMC5062546.\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/NAD.avif?v=1779880634\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/NAD.avif?v=1779880634\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"500mg","offer_id":53240040554796,"sku":"VIT-CAP-NAD-500MG770877","price":126.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/nad-500-1740649446196.png?v=1779696810"},{"product_id":"semaglutide","title":"Semaglutide","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eSemaglutide research compound. Supplied as a lyophilized peptide for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cfigure class=\"table\"\u003e\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolecular Formula\u003c\/td\u003e\n\u003ctd\u003eC187H291N45O59\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCAS Number\u003c\/td\u003e\n\u003ctd\u003e910463-68-2\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolar Mass\u003c\/td\u003e\n\u003ctd\u003e4113.641 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmino Acid Sequence\u003c\/td\u003e\n\u003ctd\u003eHis-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-COOH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSynonyms\u003c\/td\u003e\n\u003ctd\u003eNN9535, NN9934, GLP1, GLP-1\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSolubility\u003c\/td\u003e\n\u003ctd\u003eWater-soluble\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganoleptic Profile\u003c\/td\u003e\n\u003ctd\u003eWhite to off-white powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComposition\u003c\/td\u003e\n\u003ctd\u003eLyophilized powder - requires reconstitution\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\u003c\/figure\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does Semaglutide work?\" id=\"how-does-semaglutide-work\"\u003eHow does Semaglutide work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eSemaglutide exerts its effects through several interconnected mechanisms:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003eGLP-1 Receptor Activation: Semaglutide binds to and activates GLP-1 receptors, which are expressed in various tissues including pancreatic islets, the gastrointestinal tract, and the central nervous system. This activation initiates intracellular signaling cascades, primarily through cyclic AMP (cAMP) and protein kinase A (PKA) pathways.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePancreatic Effects: In pancreatic β-cells, semaglutide enhances glucose-stimulated insulin secretion by increasing intracellular cAMP levels and promoting calcium influx. Simultaneously, it inhibits glucagon secretion from α-cells, contributing to improved glucose homeostasis.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCentral Nervous System Effects: Semaglutide crosses the blood-brain barrier and acts on GLP-1 receptors in the hypothalamus and brainstem. This central action modulates appetite-regulating neurons, leading to reduced food intake and increased satiety.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eGastrointestinal Effects: By slowing gastric emptying, semaglutide helps to reduce postprandial glucose excursions and contributes to the sensation of fullness.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCardiovascular System: While the exact mechanisms are not fully elucidated, semaglutide appears to have direct and indirect effects on the cardiovascular system. These may include improvements in endothelial function, reduction in inflammation, and beneficial changes in lipid metabolism.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eMetabolic Rate: Some studies suggest that semaglutide may influence energy expenditure, potentially through effects on brown adipose tissue activation, although this area requires further investigation.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHepatic Effects: Semaglutide has been shown to reduce liver fat content in patients with non-alcoholic fatty liver disease (NAFLD), possibly through improvements in insulin sensitivity and lipid metabolism.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eThe combined action of these mechanisms results in improved glycemic control, weight loss, and potential cardiovascular benefits observed in clinical studies. The complex interplay of these effects underscores the importance of continued research to fully elucidate the therapeutic potential and physiological impacts of semaglutide and other GLP-1 receptor agonists.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Research\" id=\"research\"\u003eResearch\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\u003cp\u003eGlucose Homeostasis: Semaglutide stimulates glucose-dependent insulin secretion from pancreatic β-cells while suppressing glucagon release from α-cells. This dual action contributes to improved glycemic control in individuals with type 2 diabetes mellitus (T2DM).\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAppetite Regulation: By acting on GLP-1 receptors in the hypothalamus and other brain regions associated with appetite control, semaglutide reduces food intake and promotes satiety.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eBody Weight Reduction: Through its effects on appetite and potentially other metabolic pathways, semaglutide has been shown to facilitate significant weight loss in clinical studies.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCardiovascular Effects: Research indicates that semaglutide may have beneficial effects on cardiovascular risk factors, including improvements in lipid profiles and blood pressure.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eThe most common side effects associated with semaglutide include:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eNausea\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eVomiting\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eDiarrhea\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAbdominal pain\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eConstipation\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHeadache\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eInjection site reactions (for injectable formulations)\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThese side effects are generally mild to moderate and tend to diminish over time with continued use.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eSemaglutide represents a significant advancement in GLP-1 receptor agonist research, offering a potent tool for investigating the multifaceted roles of GLP-1 signaling in metabolic and cardiovascular physiology. Its demonstrated efficacy in glycemic control, weight management, and potential cardiovascular benefits makes it a valuable subject for ongoing research in the treatment of T2DM, obesity, and related metabolic disorders. As investigations continue, semaglutide may provide insights into novel therapeutic strategies for addressing the growing global burden of metabolic and cardiovascular diseases.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC8775408\/\"\u003eLaurindo LF, Barbalho SM, Guiguer EL, da Silva Soares de Souza M, de Souza GA, Fidalgo TM, Araújo AC, de Souza Gonzaga HF, de Bortoli Teixeira D, de Oliveira Silva Ullmann T, Sloan KP, Sloan LA. GLP-1a: Going beyond Traditional Use. Int J Mol Sci. 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34942372\/\"\u003eChao AM, Tronieri JS, Amaro A, Wadden TA. Semaglutide for the treatment of obesity. Trends Cardiovasc Med. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34305810\/\"\u003eSmits MM, Van Raalte DH. Safety of Semaglutide. Front Endocrinol (Lausanne). 2021.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33667417\/\"\u003eDavies M, Færch L, Jeppesen OK, Pakseresht A, Pedersen SD, Perreault L, Rosenstock J, Shimomura I, Viljoen A, Wadden TA, Lingvay I; STEP 2 Study Group. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36322838\/\"\u003eWeghuber D, Barrett T, Barrientos-Pérez M, Gies I, Hesse D, Jeppesen OK, Kelly AS, Mastrandrea LD, Sørrig R, Arslanian S; STEP TEENS Investigators. Once-Weekly Semaglutide in Adolescents with Obesity. N Engl J Med. 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36578889\/\"\u003eTan HC, Dampil OA, Marquez MM. Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-Analysis. J ASEAN Fed Endocr Soc. 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33625476\/\"\u003eWadden TA, Bailey TS, Billings LK, Davies M, Frias JP, Koroleva A, Lingvay I, O'Neil PM, Rubino DM, Skovgaard D, Wallenstein SOR, Garvey WT; STEP 3 Investigators. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34706925\/\"\u003eSingh G, Krauthamer M, Bjalme-Evans M. Wegovy (semaglutide): a new weight loss drug for chronic weight management. J Investig Med. 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32213703\/\"\u003eGabery S, Salinas CG, Paulsen SJ, Ahnfelt-Rønne J, Alanentalo T, Baquero AF, Buckley ST, Farkas E, Fekete C, Frederiksen KS, Helms HCC, Jeppesen JF, John LM, Pyke C, Nøhr J, Lu TT, Polex-Wolf J, Prevot V, Raun K, Simonsen L, Sun G, Szilvásy-Szabó A, Willenbrock H, Secher A, Knudsen LB, Hogendorf WFJ. Semaglutide lowers body weight in rodents via distributed neural pathways. JCI Insight. 2020.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37672701\/\"\u003eDandona P, Chaudhuri A, Ghanim H. Semaglutide in Early Type 1 Diabetes. N Engl J Med. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28266779\/\"\u003eBlundell J, Finlayson G, Axelsen M, Flint A, Gibbons C, Kvist T, Hjerpsted JB. Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity. Diabetes Obes Metab. 2017.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35131037\/\"\u003eKadowaki T, Isendahl J, Khalid U, Lee SY, Nishida T, Ogawa W, Tobe K, Yamauchi T, Lim S; STEP 6 investigators. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. Lancet Diabetes Endocrinol. 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35650449\/\"\u003eMahapatra MK, Karuppasamy M, Sahoo BM. Therapeutic Potential of Semaglutide, a Newer GLP-1 Receptor Agonist, in Abating Obesity, Non-Alcoholic Steatohepatitis and Neurodegenerative diseases: A Narrative Review. Pharm Res. 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33969456\/\"\u003eOvergaard RV, Navarria A, Ingwersen SH, Bækdal TA, Kildemoes RJ. Clinical Pharmacokinetics of Oral Semaglutide: Analyses of Data from Clinical Pharmacology Trials. Clin Pharmacokinet. 2021.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36945734\/\"\u003eMcGuire DK, Busui RP, Deanfield J, Inzucchi SE, Mann JFE, Marx N, Mulvagh SL, Poulter N, Engelmann MDM, Hovingh GK, Ripa MS, Gislum M, Brown-Frandsen K, Buse JB. Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and\/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial. Diabetes Obes Metab. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36655300\/\"\u003eWharton S, Batterham RL, Bhatta M, Buscemi S, Christensen LN, Frias JP, Jódar E, Kandler K, Rigas G, Wadden TA, Garvey WT. Two-year effect of semaglutide 2.4 mg on control of eating in adults with overweight\/obesity: STEP 5. Obesity (Silver Spring). 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33269530\/\"\u003eFriedrichsen M, Breitschaft A, Tadayon S, Wizert A, Skovgaard D. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes Obes Metab. 2021.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36568109\/\"\u003eNiu S, Chen S, Chen X, Ren Q, Yue L, Pan X, Zhao H, Li Z, Chen X. Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model. Front Endocrinol (Lausanne). 2022.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37192005\/\"\u003eChuong V, Farokhnia M, Khom S, Pince CL, Elvig SK, Vlkolinsky R, Marchette RC, Koob GF, Roberto M, Vendruscolo LF, Leggio L. The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission. JCI Insight. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Semaglutide-1.avif?v=1779880380\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Semaglutide-1.avif?v=1779880380\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Semaglutide-2.avif?v=1779880380\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Semaglutide-2.avif?v=1779880380\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53240040751404,"sku":"PEP-VIL-SEMAG-5MG969178","price":53.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/new-semag-1741424756224.png?v=1779696813"},{"product_id":"ara-290","title":"ARA-290","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eARA-290 research compound, also known as Cibinetide. Supplied as a lyophilized peptide reference material for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eThis product is purity-tested for compound identity and is intended for in vitro experimentation, analytical reference, or scientific characterization studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cfigure class=\"table\"\u003e\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolecular Formula\u003c\/td\u003e\n\u003ctd\u003eC51H84N16O21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCAS\u003c\/td\u003e\n\u003ctd\u003e1208243-50-8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolar Mass\u003c\/td\u003e\n\u003ctd\u003e1686.97 g\/mol\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChemical Formula\u003c\/td\u003e\n\u003ctd\u003e C51H84N16O21\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmino Acid Sequence\u003c\/td\u003e\n\u003ctd\u003ePyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSynonyms\u003c\/td\u003e\n\u003ctd\u003ePyroglutamate Helix B Surface Peptide, pHBSP, ARA 290, Cibinetide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSolubility\u003c\/td\u003e\n\u003ctd\u003eWater-soluble\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganoleptic Profile\u003c\/td\u003e\n\u003ctd\u003eWhite to off-white powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComposition\u003c\/td\u003e\n\u003ctd\u003eLyophilized powder - requires reconstitution\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\u003c\/figure\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does ARA-290 work?\" id=\"how-does-ara-290-work\"\u003eHow does ARA-290 work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eARA-290 exerts its effects by selectively activating the innate repair receptor (IRR), a heteromeric complex composed of EPO receptor (EPOR) and β common receptor (βcR) subunits. This specific interaction triggers a cascade of signaling events that lead to anti-inflammatory, tissue-protective, and repair-promoting effects. ARA-290 has been shown to modulate the immune response by reducing the production of pro-inflammatory cytokines and increasing the expression of anti-inflammatory mediators. Additionally, it promotes the survival and function of various cell types, including endothelial cells, cardiomyocytes, and neurons, under stress conditions.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"ARA 290 Peptide Benefits\" id=\"ara-290-peptide-benefits\"\u003eARA 290 Peptide Benefits\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eStudies investigating ara 290 peptide benefits suggest potential activity across multiple biological systems:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eNeuroprotection: ARA-290 has demonstrated neuroprotective properties in models of spinal cord injury, traumatic brain injury, and ischemic stroke, reducing neuronal damage and promoting functional recovery.\u003c\/li\u003e\n\u003cli\u003eCardioprotection: Studies have shown that ARA-290 can protect the heart from ischemia-reperfusion injury, reduce infarct size, and improve cardiac function in animal models of myocardial infarction.\u003c\/li\u003e\n\u003cli\u003eRenal protection: ARA-290 has been found to attenuate renal injury and improve kidney function in preclinical models of acute kidney injury and chronic kidney disease.\u003c\/li\u003e\n\u003cli\u003eAnti-inflammatory effects: The peptide exhibits potent anti-inflammatory properties, reducing the production of pro-inflammatory cytokines and promoting the resolution of inflammation in various tissues.\u003c\/li\u003e\n\u003cli\u003eWound healing: ARA-290 has been shown to accelerate wound healing and promote tissue repair in animal models of skin, corneal, and intestinal injuries.\u003c\/li\u003e\n\u003cli\u003ePain relief: Clinical studies have demonstrated that ARA-290 has been studied in clinical research populations.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"ARA 290 Side Effects\" id=\"ara-290-side-effects\"\u003eARA 290 Side Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eAvailable clinical data suggest ara 290 side effects are minimal and that the compound has been generally well tolerated in controlled trials.\u003cbr\u003eImportantly, unlike erythropoietin, ARA 290 peptide does not stimulate red blood cell production, which may reduce risks associated with erythropoiesis, such as thrombotic complications. However, as with all research compounds, further long-term evaluation is required.\u003cbr\u003e \u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Preparation\" id=\"preparation\"\u003ePreparation\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eARA-290 Experimental Reagent: Preparation Guidelines\nImportant: Please read these instructions carefully before handling the ARA-290 experimental reagent.\u003c\/p\u003e\n\u003cp\u003e\nDissolution:\u003c\/p\u003e\n\u003cul\u003e\u003cli\u003e\u003cp\u003eDue to the high density of ARA-290, dissolve 12mg of the reagent in a minimum of 3ml of bacteriostatic water (BAC water).\u003c\/p\u003e\u003c\/li\u003e\u003c\/ul\u003e\n\u003cp\u003ePreparation Steps:\u003c\/p\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003eRemove the experimental reagent from storage and allow it to reach room temperature (approximately 2-3 hours).\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eOnce at room temperature, add the appropriate amount of BAC water.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAfter reconstitution, keep the solution at room temperature. Do not refrigerate or refreeze.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003eCaution:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eReconstituting or storing the reagent in low-temperature environments may cause cloudiness.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAvoid exposing the reconstituted solution to cold temperatures to maintain its clarity and effectiveness.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eFor optimal results, please follow these guidelines closely.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eARA 290 peptide is a promising synthetic peptide that mimics the tissue-protective and repair-promoting properties of EPO without stimulating erythropoiesis. By selectively activating the innate repair receptor, ARA-290 exerts potent anti-inflammatory, neuroprotective, cardioprotective, and renoprotective effects in various preclinical models. Clinical studies have also demonstrated its potential in tissue-protective effects and wound research. With its favorable safety profile and wide-ranging therapeutic potential, ARA-290 represents an exciting avenue for the development of novel treatments for a variety of conditions characterized by tissue damage and inflammation.\u003c\/p\u003e\n\u003cp\u003eFor laboratories searching for ara 290 for sale or looking to buy ara 290, sourcing from a reputable research-grade supplier with verified purity and analytical validation is essential to ensure experimental accuracy.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24555851\/\"\u003evan Velzen M, Heij L, Niesters M, Cerami A, Dunne A, Dahan A, Brines M. ARA 290 for treatment of small fiber neuropathy in sarcoidosis. Expert Opin Investig Drugs. 2014\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26774587\/\"\u003eZhang W, Yu G, Zhang M. ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception. Peptides. 2016\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34343617\/\"\u003eAl-Onaizi MA, Thériault P, Lecordier S, Prefontaine P, Rivest S, ElAli A. Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression. Brain Behav Immun. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25387363\/\"\u003eBrines M, Dunne AN, van Velzen M, Proto PL, Ostenson CG, Kirk RI, Petropoulos IN, Javed S, Malik RA, Cerami A, Dahan A. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol Med. 2015\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26683514\/\"\u003eWatanabe M, Lundgren T, Saito Y, Cerami A, Brines M, Östenson CG, Kumagai-Braesch M. A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted Islets. Transplantation. 2016\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35317117\/\"\u003eMohtavinejad N, Hajiramezanali M, Akhlaghi M, Bitarafan-Rajabi A, Gholipour N. Synthesis and evaluation of 99mTc-DOTA-ARA-290 as potential SPECT tracer for targeting cardiac ischemic region. Iran J Basic Med Sci. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24136731\/\"\u003eDahan A, Dunne A, Swartjes M, Proto PL, Heij L, Vogels O, van Velzen M, Sarton E, Niesters M, Tannemaat MR, Cerami A, Brines M. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Mol Med. 2013\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27507833\/\"\u003eAtkins C, Wilson AM. Managing fatigue in sarcoidosis - A systematic review of the evidence. Chron Respir Dis. 2017\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24603865\/\"\u003eLiu Y, Luo B, Han F, Li X, Xiong J, Jiang M, Yang X, Wu Y, Zhang Z. Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection. PLoS One. 2014\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36741836\/\"\u003eWinicki NM, Nanavati AP, Morrell CH, Moen JM, Axsom JE, Krawczyk M, Petrashevskaya NN, Beyman MG, Ramirez C, Alfaras I, Mitchell SJ, Juhaszova M, Riordon DR, Wang M, Zhang J, Cerami A, Brines M, Sollott SJ, de Cabo R, Lakatta EG. A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan. Front Cardiovasc Med. 2023\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ARA-290.avif?v=1779878381\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ARA-290.avif?v=1779878381\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"12mg","offer_id":53240040948012,"sku":"PEP-VIL-ARA290-12MG866117","price":36.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ara-290-1735842059196.png?v=1779696817"},{"product_id":"selank-research-kit","title":"Selank Research Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eSelank research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e C₂₃H₄₁N₉O₇\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e129954-34-3\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e555.64 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eThr-Lys-Pro-Arg\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eTP-7, Immunomodulator Selank, Antidepressant Selank, Selanc\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eSynthetic peptide - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Specifications\" id=\"specifications\"\u003eSpecifications\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eKit Contents:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003e1 Amber glass nasal spray bottle (10ml capacity)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePrecision nasal applicator with metered dosing (0.12ml per spray)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNasal spray reconstitution solution (7ml)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eSelank 10mg Lyophilized vial\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eNote: Syringes and alcohol wipes required for reconstitution are not included in this kit \u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How is Selank Used in Research?\" id=\"how-is-selank-used-in-research\"\u003eHow is Selank Used in Research?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:12pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eIn research settings, Selank is applied in several experimental frameworks designed to evaluate its behavior and interactions:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePeptide-receptor binding studies:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Researchers examine how Selank interacts with neuropeptide receptors and cell-surface proteins in controlled models, often using receptor-binding assays or molecular docking simulations.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eNeurochemical monitoring:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory methods such as microdialysis and chromatography are used to observe changes in neurotransmitter activity, turnover, and metabolite formation.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eFormulation and stability testing:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Selank is reconstituted and monitored under varied storage and environmental conditions to study solution stability, degradation pathways, and handling requirements.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eDelivery system comparisons:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Precision spray kits and other delivery tools are employed to analyze dispersion, absorption patterns, and reproducibility across application formats in laboratory settings.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Areas of Study\" id=\"areas-of-study\"\u003eAreas of Study\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:12pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eResearch on Selank has been directed toward distinct domains within experimental neuroscience and peptide chemistry:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eNeurotransmitter pathways:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Research has examined Selank in laboratory models to study interactions with GABAergic and monoaminergic systems and to observe changes in neurotransmitter signaling under controlled conditions.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eGene expression modulation:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Experimental studies have explored its association with gene expression patterns tied to neurotransmission, receptor activity, and intracellular signaling processes.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eCognitive and behavioral models:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Selank has been used in animal-based research to explore molecular and neurochemical pathways in models of learning, memory, and stress responses, without implying outcomes or benefits.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eComparative peptide pharmacology:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory studies have compared Selank with related peptides to characterize molecular activity, receptor binding interactions, and experimental behavior under controlled conditions.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePeptide formulation science:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Research has focused on the physicochemical properties of Selank in solution, including solubility, aggregation, and compatibility with various experimental delivery systems.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eThe Selank 10mg Research Spray Kit provides researchers with a synthetic peptide preparation and a precision delivery system for controlled experimental use. This kit enables structured investigation into peptide stability, dispersion, molecular interactions, and comparative delivery methods. Supplied as a lyophilized powder, Selank must be reconstituted prior to laboratory applications. \u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.38;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003ca style=\"text-decoration:none;\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4757669\/\"\u003e\u003cspan style=\"background-color:transparent;color:#1155cc;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"-webkit-text-decoration-skip:none;font-style:normal;font-variant:normal;font-weight:400;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cu\u003eSelank Administration Affects the Expression of Some Genes Involved in GABAergic Neurotransmission\u003c\/u\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.38;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003ca style=\"text-decoration:none;\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC5322660\/\"\u003e\u003cspan style=\"background-color:transparent;color:#1155cc;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"-webkit-text-decoration-skip:none;font-style:normal;font-variant:normal;font-weight:400;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cu\u003ePeptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in Rats\u003c\/u\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.38;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003ca style=\"text-decoration:none;\" target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/www.researchgate.net\/publication\/274892094_Effects_of_heptapeptide_selank_on_the_content_of_monoamines_and_their_metabolites_in_the_brain_of_BALBC_and_C57BL6_mice_A_comparative_study\"\u003e\u003cspan style=\"background-color:transparent;color:#1155cc;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"-webkit-text-decoration-skip:none;font-style:normal;font-variant:normal;font-weight:400;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cu\u003eEffects of heptapeptide selank on the content of monoamines and their metabolites in the brain of BALB\/C and C57BL\/6 mice: A comparative study\u003c\/u\u003e\u003c\/span\u003e\u003c\/span\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Selank_Research_Kit.avif?v=1779878265\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Selank_Research_Kit.avif?v=1779878265\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg\/7ml","offer_id":53240041046316,"sku":"CHE-KIT-SLK-10MG292191","price":71.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-_77_-1756385917822.png?v=1779696818"},{"product_id":"oxytocin-spray","title":"Oxytocin Research Spray Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eOxytocin research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC43H66N12O12S2\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e50-56-6\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e1007.19 g\/mol \u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eCys-Tyr-Ile-Gln-Asn-Cys-Pro-Leu-Gly\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eα-Hypophamine, Oxytocin, Syntocinon\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized vial - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Specifications\" id=\"specifications\"\u003eSpecifications\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eKit Contents:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003e1 Amber glass nasal spray bottle (10ml capacity)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePrecision nasal applicator with metered dosing (0.12ml per spray)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNasal spray reconstitution solution (7ml)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eOxytocin 10mg Lyophilized vial\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cem\u003e\u003cstrong\u003eNote: Syringes and alcohol wipes required for reconstitution are not included in this kit \u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does Oxytocin work?\" id=\"how-does-oxytocin-work\"\u003eHow does Oxytocin work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eOxytocin exerts its effects by binding to specific G protein-coupled receptors, known as oxytocin receptors (OXTRs), which are expressed in various tissues throughout the body, including the brain, uterus, and mammary glands. Upon binding to OXTRs, oxytocin triggers intracellular signaling cascades that lead to diverse physiological responses, such as uterine contractions during labor, milk ejection during lactation, and the promotion of social bonding and trust. In the central nervous system, oxytocin acts as a neuromodulator, influencing the activity of various neurotransmitter systems, such as dopamine, serotonin, and GABA. These interactions are thought to underlie oxytocin's effects on social behavior, stress regulation, and emotional processing. Oxytocin has been shown to enhance the salience of social stimuli, facilitate social recognition and memory, and reduce anxiety and stress responses in mammal models.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Benefits\" id=\"benefits\"\u003eBenefits\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\u003cp\u003eResearcher Control: Maximize experimental precision by reconstituting nasal spray peptides only when needed, extending shelf life and ensuring optimal potency throughout your research timeline.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eResearch has highlighted the potential therapeutic benefits of oxytocin in various neuropsychiatric and neurodevelopmental disorders characterized by social deficits and emotional dysregulation. For example, intranasal administration of oxytocin has been found to improve social cognition, empathy, and communication skills in individuals with autism spectrum disorder (ASD). Similarly, oxytocin has shown promise in the treatment of social anxiety disorder, enhancing the effectiveness of exposure therapy and reducing amygdala reactivity to fearful faces.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eOxytocin has also been investigated as a potential treatment for schizophrenia, particularly in addressing negative symptoms such as social withdrawal and anhedonia. Studies have demonstrated that oxytocin administration can improve social cognition, facial emotion recognition, and theory of mind in individuals with schizophrenia. In addition to its effects on social behavior, oxytocin has been shown to have analgesic properties, reducing pain sensitivity and promoting wound healing. This has led to the exploration of oxytocin as a potential therapeutic agent for chronic pain conditions, such as fibromyalgia and migraine.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eOxytocin's role in stress regulation and anxiety has also been extensively studied. Research suggests that oxytocin may have anxiolytic effects, reducing the activity of the hypothalamic-pituitary-adrenal (HPA) axis and attenuating the stress response. This has implications for the potential use of oxytocin in the treatment of stress-related disorders, such as post-traumatic stress disorder (PTSD) and generalized anxiety disorder (GAD). Furthermore, oxytocin has been implicated in the regulation of appetite and food intake. Studies have shown that oxytocin administration can reduce caloric intake and increase energy expenditure, suggesting its potential as a therapeutic target for obesity and metabolic disorders.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eWhile oxytocin is generally well-tolerated, some potential side effects have been reported, particularly when administered at high doses or for prolonged periods. These may include\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eHeadache\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNausea\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eGastrointestinal discomfort\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eDizziness\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAllergic reactions (rare)\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eIt is essential to note that the long-term safety and efficacy of oxytocin administration, particularly for neuropsychiatric indications, require further investigation in large-scale clinical trials.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eOxytocin is a neuropeptide hormone with a wide range of physiological functions, including its well-known roles in social bonding, sexual reproduction, and stress regulation. The potential therapeutic applications of oxytocin in neuropsychiatric and neurodevelopmental disorders, such as autism spectrum disorder, social anxiety disorder, schizophrenia, chronic pain conditions, and metabolic disorders, have garnered significant attention in recent years. While research has shown promising results, further large-scale clinical trials are needed to establish the long-term safety and efficacy of oxytocin administration for these indications. As a research peptide, oxytocin continues to be a valuable tool in elucidating the complex mechanisms underlying social behavior, emotional processing, stress regulation, and appetite control, paving the way for the development of novel therapeutic strategies for a range of neuropsychiatric and metabolic conditions.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22265852\/#:~:text=These%20findings%20include%20that%20oxytocin,and%20strategic%20levels%20of%20processing.\"\u003eGuastella AJ, MacLeod C. A critical review of the influence of oxytocin nasal spray on social cognition in humans: evidence and future directions. Horm Behav. 2012 Mar;61(3):410-8. doi: 10.1016\/j.yhbeh.2012.01.002. Epub 2012 Jan 11. Erratum in: Horm Behav. 2012 May;61(5):773. Graustella, Adam J [corrected to Guastella, Adam J]. PMID: 22265852.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32912963\/\"\u003eHuang, Y., Kendrick, K. M., \u0026amp; Yu, R. (2020). Oxytocin and social adaptation in humans. Trends in Cognitive Sciences, 24(11), 927-939.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28867943\/\"\u003eKeech, B., Crowe, S., \u0026amp; Hocking, D. R. (2018). Intranasal oxytocin, social cognition and neurodevelopmental disorders: A meta-analysis. Psychoneuroendocrinology, 87, 9-19.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32981445\/\"\u003eRash, J. A., Aguirre-Camacho, A., \u0026amp; Campbell, T. S. (2020). Oxytocin and pain: a systematic review and synthesis of findings. The Clinical Journal of Pain, 36(3), 204-213. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28812265\/\"\u003eFeifel, D., MacDonald, K., Cobb, P., \u0026amp; Minassian, A. (2012). Adjunctive intranasal oxytocin improves verbal memory in people with schizophrenia. Schizophrenia Research, 139(1-3), 207-210. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30506703\/\"\u003eNeumann, I. D., \u0026amp; Slattery, D. A. (2016). Oxytocin in general anxiety and social fear: a translational approach. Biological Psychiatry, 79(3), 213-221. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33670047\/\"\u003eHorta, M., Kaylor, K., Feifel, D., \u0026amp; Ebner, N. C. (2020). Chronic oxytocin administration as a tool for investigation and treatment: a cross-disciplinary systematic review. Neuroscience \u0026amp; Biobehavioral Reviews, 108, 1-23. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30193705\/\"\u003eLawson, E. A. (2017). The effects of oxytocin on eating behaviour and metabolism in humans. Nature Reviews Endocrinology, 13(12), 700-709. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28812272\/\"\u003eFeifel, D., Shilling, P. D., \u0026amp; MacDonald, K. (2016). A review of oxytocin's effects on the positive, negative, and cognitive domains of schizophrenia. Biological Psychiatry, 79(3), 222-233. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34639199\/\"\u003eErdozain, A. M., \u0026amp; Peñagarikano, O. (2020). Oxytocin as a treatment for social cognition, not there yet. Frontiers in Psychiatry, 10, 930. \u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Oxytocin_Research_Spray_Kit.avif?v=1779877383\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Oxytocin_Research_Spray_Kit.avif?v=1779877383\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg\/7ml","offer_id":53240041275692,"sku":"9635848454651","price":54.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/oxytocin-nasal-spray-kit-1746197990107.png?v=1779696823"},{"product_id":"semax-research-kit","title":"Semax Research Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eSemax research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC38H54N12O9\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e80714-61-0\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e826.92 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eMet-Glu-His-Phe-Pro-Gly-Pro\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eSem@x, MEHFPGP, Heptapeptide\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Specifications\" id=\"specifications\"\u003eSpecifications\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eKit Contents:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003e1 Amber glass nasal spray bottle (10ml capacity)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePrecision nasal applicator with metered dosing (0.12ml per spray)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNasal spray reconstitution solution (7ml)\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eSem@x 30mg Lyophilized vial\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cem\u003e\u003cstrong\u003eNote: Syringes and alcohol wipes required for reconstitution are not included in this kit \u003c\/strong\u003e\u003c\/em\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does Sem@x work?\" id=\"how-does-semx-work\"\u003eHow does Sem@x work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eSem@x may exert effects through multiple mechanisms in research settings. It has been studied in relation to neurotrophic factor (BDNF) and nerve growth factor (NGF), which are of interest in neurological research. Sem@x has been investigated for its potential relationship to serotonergic and dopaminergic systems in laboratory studies. Additionally, research suggests Sem@x may have antioxidant and anti-inflammatory properties in experimental models, potentially interacting with oxidative stress and inflammation-related processes. Studies indicate it may influence beta-amyloid peptides, which are of interest in neurological research. Research also suggests Sem@x may affect circulation parameters in experimental models, potentially influencing oxygen and nutrient delivery in tissue cultures.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Research Applications\" id=\"research-applications\"\u003eResearch Applications\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eResearch studies have highlighted several potential areas of interest regarding Sem@x peptide:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eCognitive processes: Sem@x has been studied for its potential interactions with memory, learning, and attention in various mammalian models and preliminary clinical investigations.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNeuronal interactions: Research suggests Sem@x may exhibit properties that could potentially interact with neuronal function and viability in the context of various laboratory challenges.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eNeurotransmitter research: Sem@x has been investigated for its potential relationship to anxiolytic and mood-related processes in research models, possibly through its interaction with serotonergic and dopaminergic systems.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eCirculatory function: Research with Sem@x has shown potential in models studying functional parameters and neurological responses following ischemic conditions in experimental settings.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eDegenerative process research: Sem@x has been explored as a subject of interest in research concerning neurodegenerative processes, due to its potential neuroprotective and cognitive-related properties in laboratory studies.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Observations in Studies\" id=\"observations-in-studies\"\u003eObservations in Studies\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\u003cp\u003eSem@x is generally well-tolerated, with few reported side effects in clinical trials. However, as with any research compound, caution should be exercised, and further studies are needed to fully understand its safety profile. Potential side effects may include\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHeadache\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eDizziness\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eSem@x peptide is a promising research compound with potential cognitive-related, neuroprotective, and mood-regulating properties in experimental settings. Its ability to potentially interact with neurotrophic factors, neurotransmitter systems, and inflammatory processes has sparked interest in various neurological research areas. While the results from preclinical studies and clinical investigations are encouraging, further research may help to fully elucidate its mechanisms of action, safety profile, and research applications. As a research chemical, Sem@x peptide offers a potentially valuable tool for investigating the complexities of the brain and developing novel approaches for neurological research.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33418449\/\"\u003eGlazova NY, Manchenko DM, Volodina MA, Merchieva SA, Andreeva LA, Kudrin VS, Myasoedov NF, Levitskaya NG. Semax, synthetic ACTH(4-10) analogue, attenuates behavioural and neurochemical alterations following early-life fluvoxamine exposure in white rats. Neuropeptides. 2021 Apr;86:102114. doi: 10.1016\/j.npep.2020.102114. Epub 2020 Dec 28. PMID: 33418449.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35080861\/\"\u003eSciacca MFM, Naletova I, Giuffrida ML, Attanasio F. Semax, a Synthetic Regulatory Peptide, Affects Copper-Induced Abeta Aggregation and Amyloid Formation in Artificial Membrane Models. ACS Chem Neurosci. 2022 Feb 16;13(4):486-496. doi: 10.1021\/acschemneuro.1c00707. Epub 2022 Jan 26. PMID: 35080861; PMCID: PMC8855339.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/16635254\/\"\u003eDolotov OV, Karpenko EA, Inozemtseva LS, Seredenina TS, Levitskaya NG, Rozyczka J, Dubynina EV, Novosadova EV, Andreeva LA, Alfeeva LY, Grivennikov IA, Myasoedov NF. Semax, an analog of ACTH(4-10) with cognitive effects, regulates BDNF and trkB expression in the rat hippocampus. Brain Res. 2006.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28255762\/\"\u003eMedvedeva EV, Dmitrieva VG, Limborska SA, Myasoedov NF, Dergunova LV. Semax, an analog of ACTH(4-7), regulates expression of immune response genes during ischemic brain injury in rats. Mol Genet Genomics. 2017 Jun;292(3):635-653. doi: 10.1007\/s00438-017-1297-1. Epub 2017 Mar 2. PMID: 28255762.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29798983\/\"\u003e Gusev EI, Martynov MY, Kostenko EV, Petrova LV, Bobyreva SN. Éffektivnost' semaksa pri lechenii bol'nykh na raznykh stadiiakh ishemicheskogo insul'ta [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]. Zh Nevrol Psikhiatr Im S S Korsakova. 2018;118(3. Vyp. 2):61-68. Russian. doi: 10.17116\/jnevro20181183261-68. PMID: 29798983.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30225715\/\"\u003eLebedeva IS, Panikratova YR, Sokolov OY, Kupriyanov DA, Rumshiskaya AD, Kost NV, Myasoedov NF. Effects of Semax on the Default Mode Network of the Brain. Bull Exp Biol Med. 2018 Sep;165(5):653-656. doi: 10.1007\/s10517-018-4234-3. Epub 2018 Sep 17. PMID: 30225715.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/19633950\/\"\u003eDmitrieva VG, Povarova OV, Skvortsova VI, Limborska SA, Myasoedov NF, Dergunova LV. Semax and Pro-Gly-Pro activate the transcription of neurotrophins and their receptor genes after cerebral ischemia. Cell Mol Neurobiol. 2010 Jan;30(1):71-9. doi: 10.1007\/s10571-009-9432-0. Epub 2009 Jul 25. PMID: 19633950.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24661604\/\"\u003eMedvedeva EV, Dmitrieva VG, Povarova OV, Limborska SA, Skvortsova VI, Myasoedov NF, Dergunova LV. The peptide semax affects the expression of genes related to the immune and vascular systems in rat brain focal ischemia: genome-wide transcriptional analysis. BMC Genomics. 2014 Mar 24;15:228. doi: 10.1186\/1471-2164-15-228. PMID: 24661604; PMCID: PMC3987924.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32342318\/\"\u003ePanikratova YR, Lebedeva IS, Sokolov OY, Rumshiskaya AD, Kupriyanov DA, Kost NV, Myasoedov NF. Functional Connectomic Approach to Studying Selank and Semax Effects. Dokl Biol Sci. 2020 Jan;490(1):9-11. doi: 10.1134\/S001249662001007X. Epub 2020 Apr 27. PMID: 32342318.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27411820\/\"\u003eInozemtsev AN, Bokieva SB, Karpukhina OV, Gumargalieva KZ, Kamensky AA, Myasoedov NF. Semax prevents learning and memory inhibition by heavy metals. Dokl Biol Sci. 2016 May;468(1):112-4. doi: 10.1134\/S0012496616030066. Epub 2016 Jul 14. PMID: 27411820.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n\u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Semax_Research_Kit.avif?v=1779877271\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Semax_Research_Kit.avif?v=1779877271\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e  \n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"30mg\/7ml","offer_id":53240041308460,"sku":"CHE-KIT-SMX-30MG793753","price":59.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-_76_-1756386094208.png?v=1779696824"},{"product_id":"comprehensive-peptide-bundle","title":"Comprehensive Peptide Bundle","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eMulti-peptide research bundle. Includes multiple lyophilized peptide reference compounds packaged together for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eEach component is individually purity-tested. Intended for in vitro experimentation and analytical reference studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240041373996,"sku":"9635848505182","price":115.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-_93_-1756737162374.png?v=1779696826"},{"product_id":"bpc-157-tablets","title":"BPC-157 500mcg (60 tablets)","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eBPC-157 research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC62H98N16O22\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\t\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e137525-51-0\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e773.895 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eGVSWGLR\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eBpc-157, 137525-51-0, Bpc 157, Bepecin Bpc 15, Bpc157, Body protection compound 15\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eOral tablets (500mcg BPC-157 per tablet)\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does BPC-157 work?\" id=\"how-does-bpc-157-work\"\u003eHow does BPC-157 work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eBPC-157 is believed to work through several mechanisms to support healing and tissue regeneration. One of its primary actions is promoting angiogenesis, the formation of new blood vessels. This increased blood flow can help deliver oxygen and nutrients to damaged tissues, facilitating repair and regeneration. BPC-157 has also been shown to stimulate the production of collagen, a key protein in connective tissues such as tendons and ligaments.\u003c\/p\u003e\n\u003cp\u003eAdditionally, BPC-157 may have anti-inflammatory properties, helping to reduce inflammation and oxidative stress in various tissues. This can create a more favorable environment for healing and may help alleviate pain associated with injuries or inflammatory conditions.\u003c\/p\u003e\n\u003cp\u003eBPC-157 has also demonstrated neuroprotective effects, potentially helping to protect and regenerate nerve cells. This may be beneficial in conditions involving nerve damage or degeneration.\u003c\/p\u003e\n\u003cp\u003eFurthermore, BPC-157 has been shown to interact with the nitric oxide (NO) system, which plays a role in various physiological processes, including blood vessel dilation and tissue repair. By modulating the NO system, BPC-157 may help regulate blood flow and support healing processes.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Benefits\" id=\"benefits\"\u003eBenefits\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eBPC-157 has been studied for its potential benefits in various health conditions:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003eMay help accelerate wound healing\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePromotes tissue regeneration\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eSupports repair of tendons, ligaments, and muscles\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eShows promise in the treatment of inflammatory bowel disease\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePotential benefits in treating joint and tendon injuries\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eDemonstrates neuroprotective properties\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAnti-inflammatory and antioxidant effects\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eIn animal studies, BPC-157 has been well-tolerated with no reported severe side effects. However, as with any substance, individual responses may vary. More research is needed to fully understand the potential side effects of BPC-157 in mammals, including long-term safety.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eBPC-157 is a promising synthetic peptide derived from a protein found in gastric juice. Research has shown its potential to support healing processes, promote tissue regeneration, and reduce inflammation in various tissues. BPC-157 may work by stimulating angiogenesis, collagen production, and modulating the nitric oxide system. It has been studied for its potential benefits in treating conditions such as inflammatory bowel disease, joint and tendon injuries, and skin wounds. Additionally, BPC-157 has demonstrated neuroprotective properties and may help reduce oxidative stress. While more research is needed to fully understand its mechanisms of action and long-term safety in humans, BPC-157 continues to be a subject of interest for its potential therapeutic applications.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.718147\/full\"\u003eVukojevic, Katarina et al. \"Stable gastric pentadecapeptide BPC 157 and wound healing.\" Frontiers in pharmacology vol. 12 718147\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34267654\/\"\u003eGwyer, Danielle et al. \"Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.\" Cell and tissue research vol. 383,3 (2021)\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36551977\/\"\u003eKalogjera, Livije et al. \"Stable Gastric Pentadecapeptide BPC 157 in the Therapy of the Nasal Mucosa, Periodontium, and Dry Eye Syndrome.\" Biomedicines vol. 10,12 3281. 7 Dec. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31158953\/\"\u003eSikiric, Predrag et al. \"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.\" Current neuropharmacology vol. 17,11 (2019)\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35449779\/\"\u003eKnezevic, Maro et al. \"Stable Gastric Pentadecapeptide BPC 157 Therapy for Periodontitis in Rats.\" Biomedicines vol. 10,4 859. 6 Apr. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35125818\/\"\u003eKokot, Antonio et al. \"Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats.\" Frontiers in pharmacology vol. 13 861711. 18 Feb. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35052769\/\"\u003eKnezevic, Maro et al. \"Stable Gastric Pentadecapeptide BPC 157 and Periodontal Healing in Rats.\" Biomedicines vol. 10,2 265. 25 Jan. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34203464\/\"\u003eSever, Marko et al. \"Stable Gastric Pentadecapeptide BPC 157 Therapy for Periodontitis in Rats.\" Biomedicines vol. 9,7 774. 29 Jun. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32547687\/\"\u003eSikiric, Predrag et al. \"Stable Gastric Pentadecapeptide BPC 157-NO-system Relation.\" Current pharmaceutical design vol. 26,25 (2020)\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/#:~:text=In%20conclusion%2C%20BPC%20157%20promotes,of%20the%20FAK%2Dpaxillin%20pathway.\"\u003eChang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011 Mar;110(3):774-80. doi: 10.1152\/japplphysiol.00945.2010. Epub 2010 Oct 28. PMID: 21030672\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_500mcg_60_tablets.avif?v=1779875483\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_500mcg_60_tablets.avif?v=1779875483\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"500mcg x 60 tablets","offer_id":53240042389804,"sku":"PEP-TAB-BPC157-500MCG868355","price":87.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-20250303-094435-1741171984298.png?v=1779696843"},{"product_id":"bpc-157-tb-500-ghk-cu-blend","title":"BPC-157 10mg + TB-500 10mg + GHK-Cu 50mg (70mg blend)","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eMulti-peptide research blend. Multiple lyophilized peptide compounds supplied as a combined preparation for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for in vitro experimentation or analytical reference studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBPC-157: C₆₂H₉₈N₁₆O₂₂ \u003c\/p\u003e\n\u003cp\u003eTB-500: C₄₄H₆₉N₁₁O₁₂ GHK-Cu: C₁₄H₂₄N₆O₃·Cu\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBPC-157: 137525-51-0 \u003c\/p\u003e\n\u003cp\u003eTB-500: 77591-33-4 \u003c\/p\u003e\n\u003cp\u003eGHK-Cu: 89030-95-5\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBPC-157: 1419.6 g\/mol \u003c\/p\u003e\n\u003cp\u003eTB-500: 928.1 g\/mol \u003c\/p\u003e\n\u003cp\u003eGHK-Cu: 426.9 g\/mol \u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val \u003c\/p\u003e\n\u003cp\u003eTB-500: Ac-Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser \u003c\/p\u003e\n\u003cp\u003eGHK-Cu: Gly-His-Lys-Cu\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBPC-157: Body Protection Compound-157, Pentadecapeptide BPC-157, PL 14736 \u003c\/p\u003e\n\u003cp\u003eTB-500: Thymosin Beta-4, Tβ4, TMSB4X, Thymosin β₄ \u003c\/p\u003e\n\u003cp\u003eGHK-Cu: Copper Tripeptide-1, Glycyl-L-histidyl-L-lysine copper(II), Copper Peptide GHK\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite lyophilized powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\n\u003cp\u003eBlend of BPC-157, TB-500, GHk-Cu peptides. \u003c\/p\u003e\n\u003cp\u003eRequires reconstitution. \u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does BPC-157 + TB-500 + GHK-Cu blend work?\" id=\"how-does-bpc-157-tb-500-ghk-cu-blend-work\"\u003eHow does BPC-157 + TB-500 + GHK-Cu blend work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eResearchers have studied this peptide blend to uncover its influence on various biological pathways. The following areas of interest have been studied in the lab setting:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eBPC-157\u003c\/strong\u003e. Recent research has focused on the relationship between BPC-157 and angiogenesis and blood vessel formation through potential modulation of growth factor expression (particularly vascular endothelial growth factor (VEGF)). Additional studies have considered its effects on fibroblast migration and proliferation in experimental models.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eTB-500\u003c\/strong\u003e. TB-500’s actin-binding properties and possible role in cell migration facilitation have been a point of focus for scientists. Investigations have also reviewed its association with proteins linked to tissue processes, as well as its theoretical modulation of inflammatory cytokines in preclinical systems.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eGHK-Cu.\u003c\/strong\u003e Studies indicate that GHK-Cu may function as a copper carrier, delivering copper to sites where it can serve as a cofactor in enzymatic pathways such as collagen synthesis and extracellular matrix remodeling. Moreover, research has evaluated its role in regulating gene expression, with reported associations across thousands of genes.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eTogether, these peptides are being studied for their potential to influence angiogenesis, inflammatory pathways, and extracellular matrix dynamics in controlled laboratory research models.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Research Applications\" id=\"research-applications\"\u003eResearch Applications\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eTissue-Related Pathways. \u003c\/strong\u003eLaboratory studies have examined this blend in relation to processes such as angiogenesis, extracellular matrix dynamics, and cellular migration.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eInflammatory Signaling.\u003c\/strong\u003e Components have been investigated for their potential role in modulating cytokine activity and related inflammatory pathways in preclinical models.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eCollagen Pathways. \u003c\/strong\u003eResearch on GHK-Cu has explored its involvement in collagen synthesis and extracellular matrix organization.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eMulti-Pathway Interactions. \u003c\/strong\u003eStudies have considered the possibility that these peptides act through distinct but complementary mechanisms in experimental systems.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eAreas of Interest. \u003c\/strong\u003eOngoing investigations include applications in musculoskeletal, dermatological, and neurological research contexts under controlled laboratory conditions.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eThe BPC-157 + TB-500 + GHK-Cu blend serves as a research tool for studying angiogenesis, cell migration, collagen pathways, and extracellular matrix dynamics in preclinical models. Ongoing investigations examine its mechanisms under controlled laboratory conditions.\u003c\/p\u003e\n\u003cp\u003e\n\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29998800\/\"\u003eSeiwerth S, Rucman R, Turkovic B, Sever M, Klicek R, Radic B, Drmic D, Stupnisek M, Misic M, Vuletic LB, Pavlov KH, Barisic I, Kokot A, Japjec M, Blagaic AB, Tvrdeic A, Rokotov DS, Vrcic H, Staresinic M, Sebecic B, Sikiric P. BPC 157 and Standard Angiogenic Growth Factors. Gastrointestinal Tract Healing, Lessons from Tendon, Ligament, Muscle and Bone Healing. Curr Pharm Des. 2018;24(18):1972-1989. doi: 10.2174\/1381612824666180712110447. PMID: 29998800.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/17628536\/\"\u003eTkalcević VI, Cuzić S, Brajsa K, Mildner B, Bokulić A, Situm K, Perović D, Glojnarić I, Parnham MJ. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. Eur J Pharmacol. 2007 Sep 10;570(1-3):212-21. doi: 10.1016\/j.ejphar.2007.05.072. Epub 2007 Jun 16. PMID: 17628536.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20536467\/\"\u003eCrockford D, Turjman N, Allan C, Angel J. Thymosin beta4: structure, function, and biological properties supporting current and future clinical applications. Ann N Y Acad Sci. 2010 Apr;1194:179-89. doi: 10.1111\/j.1749-6632.2010.05492.x. PMID: 20536467.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2010.05479.x\"\u003ePhilp D, Kleinman HK. Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci. 2010;1194:81-86. doi:10.1111\/j.1749-6632.2010.05479.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC6073405\/\"\u003ePickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018 Jul 7;19(7):1987. doi: 10.3390\/ijms19071987. PMID: 29986520; PMCID: PMC6073405.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/15655171\/\"\u003ePollard JD, Quan S, Kang T, Koch RJ. Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts. Arch Facial Plast Surg. 2005 Jan-Feb;7(1):27-31. doi: 10.1001\/archfaci.7.1.27. PMID: 15655171.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.mdpi.com\/2079-9284\/2\/3\/236\"\u003ePickart, L.; Vasquez-Soltero, J.M.; Margolina, A. GHK-Cu may Prevent Oxidative Stress in Skin by Regulating Copper and Modifying Expression of Numerous Antioxidant Genes. Cosmetics 2015, 2, 236-247. https:\/\/doi.org\/10.3390\/cosmetics2030236\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25415472\/\"\u003eChang CH, Tsai WC, Hsu YH, Pang JH. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules. 2014 Nov 19;19(11):19066-77. doi: 10.3390\/molecules191119066. PMID: 25415472; PMCID: PMC6271067.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34380875\/\"\u003eVukojevic J, Milavić M, Perović D, Ilić S, Čilić AZ, Đuran N, Štrbe S, Zoričić Z, Filipčić I, Brečić P, Seiverth S, Sikirić P. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen Res. 2022 Mar;17(3):482-487. doi: 10.4103\/1673-5374.320969. PMID: 34380875; PMCID: PMC8504390.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_10mg_TB-500_10mg_GHK-Cu_50mg_70mg_blend.avif?v=1779875355\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_10mg_TB-500_10mg_GHK-Cu_50mg_70mg_blend.avif?v=1779875355\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"70mg Blend","offer_id":53240042455340,"sku":"PEP-BLD-BPTB-GHK-70MG155751","price":162.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/glow-blend-1747915605553.png?v=1779696844"},{"product_id":"foundational-peptide-bundle","title":"Foundational Peptide Bundle","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eMulti-peptide research bundle. Includes multiple lyophilized peptide reference compounds packaged together for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eEach component is individually purity-tested. Intended for in vitro experimentation and analytical reference studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240042586412,"sku":"9635850291594","price":92.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-_97_-1756735794725.png?v=1779696846"},{"product_id":"5-amino-1mq","title":"5-Amino-1MQ","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003e5-Amino-1MQ research compound, also known as 5-Amino-1-Methylquinolinium. Supplied as a lyophilized peptide reference material for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eThis product is purity-tested for compound identity and is intended for in vitro experimentation, analytical reference, or scientific characterization studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC10H11N2+\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\t\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e42464-96-0\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e 152.21 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eNot a peptide sequence but a small molecule NNMT inhibitor\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e5-Amino-1-MQ iodide, 5-Amino-1-methylquinolinium, iodide (1:1), 5-Amino-1MQ iodide\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eSoluble in Water\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003ePowder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"What Is 5 Amino 1MQ?\" id=\"what-is-5-amino-1mq\"\u003eWhat Is 5 Amino 1MQ?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eAlthough frequently searched as a 5 amino 1mq peptide, 5-Amino-1MQ is technically a small molecule NNMT inhibitor rather than a peptide. It is structurally designed to interact with metabolic enzyme pathways and has become a subject of interest in metabolic and mitochondrial research fields.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Current Research on 5-Amino-1MQ\" id=\"current-research-on-5-amino-1mq\"\u003eCurrent Research on 5-Amino-1MQ\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003e5-Amino-1MQ has been examined in laboratory research studies as an inhibitor of NNMT, an enzyme associated with cellular metabolic pathways. These areas of investigation are of particular relevance:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eNNMT Interaction.\u003c\/strong\u003e 5-Amino-1MQ may inhibit NNMT activity with possible effects on NAD+ and S-adenosylmethionine (SAM) dynamics in experimental models.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eAdipocyte Biology.\u003c\/strong\u003e Research has explored the compound’s role in adipocyte systems, including investigations into lipid accumulation patterns and related metabolic processes.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003cstrong\u003eMitochondrial Pathways.\u003c\/strong\u003e Preliminary studies suggest potential associations between 5-Amino-1MQ and mitochondrial outcomes, including investigations of biogenesis and cellular energy-related mechanisms.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Experimental Utility of 5-Amino-1MQ\" id=\"experimental-utility-of-5-amino-1mq\"\u003eExperimental Utility of 5-Amino-1MQ\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eMetabolic Pathways\u003c\/strong\u003e. Studied for its potential to interact with NNMT and influence cellular metabolism in laboratory settings.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eAdipose Tissue Function\u003c\/strong\u003e. 5-Amino-1MQ has been investigated in relation to adipocyte metabolism, particularly its potential effects on lipid accumulation patterns.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eNAD+ Dynamics\u003c\/strong\u003e. In research systems, scientists have evaluated 5-Amino-1MQ for associations with NAD+ availability and cellular energetics due to its interaction with NNMT.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMitochondrial Function\u003c\/strong\u003e. Early studies have evaluated links between 5-Amino-1MQ and mitochondrial biogenesis and function.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eMethylation Support\u003c\/strong\u003e. The compound has been considered in studies of SAM availability and methylation-dependent cellular mechanisms.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003e5-Amino-1MQ (5 amino 1mq) has been examined in laboratory studies as a small molecule inhibitor of nicotinamide N-methyltransferase (NNMT). Also known as 5 amino 1 methylquinolinium, its structure has made it a subject of interest for investigating NNMT activity and related cellular metabolic pathways.\u003c\/p\u003e\n\u003cp\u003eCurrent research on 5-Amino-1MQ remains focused on preclinical and laboratory models, where ongoing studies continue to explore its mechanisms and potential experimental applications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29155147\/\"\u003eNeelakantan H, Vance V, Wetzel MD, Wang HY, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochem Pharmacol. 2018 Jul;154:161-171. doi: 10.1016\/j.bcp.2018.05.003. Epub 2018 May 5. PMID: 29738706; PMCID: PMC6015571.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25596852\/\"\u003eKannt A, Pfenninger A, Teichert L, Tönjes A, Dietrich A, Schön MR, Klöting N, Blüher M. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia. 2015 Apr;58(4):799-808. doi: 10.1007\/s00125-014-3490-7. Epub 2015 Jan 18. PMID: 25596852; PMCID: PMC4351435.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24717514\/\"\u003eKraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014 Apr 10;508(7495):258-62. doi: 10.1038\/nature13198. PMID: 24717514; PMCID: PMC4107212.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23455543\/\"\u003eUlanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol. 2013 May;9(5):300-6. doi: 10.1038\/nchembio.1204. Epub 2013 Mar 3. PMID: 23455543; PMCID: PMC3631284.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26168293\/\"\u003eHong S, Moreno-Navarrete JM, Wei X, Kikukawa Y, Tzameli I, Prasad D, Lee Y, Asara JM, Fernandez-Real JM, Maratos-Flier E, Pissios P. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat Med. 2015 Aug;21(8):887-94. doi: 10.1038\/nm.3882. Epub 2015 Jul 13. PMID: 26168293; PMCID: PMC4529375.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/5-Amino-1MQ_Research_Kit_ea254350-10e5-43b0-a721-bbd570b13060.avif?v=1779875020\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/5-Amino-1MQ_Research_Kit_ea254350-10e5-43b0-a721-bbd570b13060.avif?v=1779875020\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"5mg","offer_id":53240042717484,"sku":"CHE-CAP-5AQ-5MG494552","price":71.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/5-amino-1mq-card-1745403309814.png?v=1779696848"},{"product_id":"ptd-dbm","title":"PTD-DBM","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003ePTD-DBM research compound. Supplied as a lyophilized peptide reference material for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eThis product is purity-tested for compound identity and is intended for in vitro experimentation, analytical reference, or scientific characterization studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC₁₂₄H₂₂₅N₆₁O₂₈S₂\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS Number\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e120287-85-6 or 1609454-11-6\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e3082.62 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eArg-Arg-Arg-Arg-Arg-Arg-Arg-Arg-Gly-Gly-Gly-Gly-Arg-Lys-Thr-Gly-His-Gln-Ile-Cys-Lys-Phe-Arg-Lys-Cys\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eProtein Transduction Domain-fused Dishevelled Binding Motif, Protein transduction domain (PTD)-Dvl-binding motif (DBM), Hair growth peptide, Follicle regeneration peptide\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite to off-white powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How is PTD-DBM Used in Research?\" id=\"how-is-ptd-dbm-used-in-research\"\u003eHow is PTD-DBM Used in Research?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003ePTD-DBM peptide mechanism of action research suggests it may primarily function as a peptide inhibitor of the CXXC5-Dishevelled protein interaction, potentially activating the Wnt\/β-catenin signaling pathway. Current studies on ptd-dbm indicate the compound may demonstrate enhanced hair follicle regeneration properties through multiple potential molecular pathways. \u003cbr\u003e\u003cbr\u003eThe primary mechanism research suggests that ptd dbm peptide may involve the competitive binding to the Dishevelled (Dvl) protein, potentially preventing CXXC5 from inhibiting the Wnt\/β-catenin pathway. By disrupting this inhibitory interaction, ptd dbm may enhance downstream signaling involved in hair follicle development and regeneration through both direct and indirect cellular pathways.\u003cbr\u003e\u003cbr\u003eAdditionally, studies indicate PTD-DBM may have effects on wound-induced hair neogenesis (WIHN) and tissue regeneration. Research suggests it may stimulate stem cells in hair follicles and possibly enhance keratinocyte proliferation, potentially contributing to improved follicle cycling and hair growth phases.\u003cbr\u003eThe peptide's protein transduction domain (PTD) structure, consisting of eight arginine residues, may allow for enhanced cellular penetration, possibly leading to more consistent therapeutic effects when applied topically to affected areas.\u003cbr\u003e\u003cbr\u003eResearch also suggests potential synergistic effects when combined with compounds like valproic acid (VPA), which may further activate the Wnt\/β-catenin pathway through GSK3β inhibition. \u003cbr\u003eFor research institutions looking to buy ptd-dbm from a verified ptd-dbm peptide supplier, sourcing high-purity material with validated analytical data is critical to ensure experimental accuracy and reproducibility.\u003cbr\u003e \u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Areas of Study\" id=\"areas-of-study\"\u003eAreas of Study\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\n\u003cstrong\u003eHair Follicle Regeneration\u003c\/strong\u003e:  Research on ptd-dbm peptide suggests it may have potential effects on new hair follicle formation and may help prevent follicle miniaturization studied in laboratory research. Studies investigating ptd dbm indicate its mechanism targeting the CXXC5–Dvl interaction may support activation of the Wnt\/β-catenin pathway, which plays a key role in follicular development.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eWound Healing\u003c\/strong\u003e: Studies indicate ptd-dbm may improve cutaneous wound healing and may offer potential benefits for tissue regeneration and collagen synthesis.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eExtended Effects\u003c\/strong\u003e: Research suggests hair growth may be maintained even after treatment cessation, potentially indicating sustained follicle activation.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eStem Cell Activation\u003c\/strong\u003e: Studies suggest it may have effects on follicle stem cell populations, potentially contributing to enhanced anagen phase duration.\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eCombination Potential\u003c\/strong\u003e: Research indicates there may be possible synergistic effects when ptd-dbm is combined with other therapeutic agents like valproic acid or microneedling procedures.\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003ePTD-DBM may represent an advancement in peptide-based hair regeneration research, in laboratory research contexts. Its unique structure targeting the CXXC5-Dvl interaction may provide a novel approach to activating hair growth pathways while potentially maintaining beneficial effects even after treatment discontinuation. Current investigations indicate that ptd-dbm may have promising research applications in both hair loss prevention and active follicle regeneration. Ongoing studies are also exploring broader regenerative potential, including wound healing and tissue repair models.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/28595998\/\"\u003eLee SH, Seo SH, Lee DH, Pi LQ, Lee WS, Choi KY. Targeting of CXXC5 by a Competing Peptide Stimulates Hair Regrowth and Wound-Induced Hair Neogenesis. Journal of Investigative Dermatology. 2017 Nov;137(11):2260-2269. doi: 10.1016\/j.jid.2017.04.038. PMID: 28942361.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26056233\/\"\u003eLee SH, Kim MY, Kim HY, Lee YM, Kim H, Nam KA, Roh MR, Min do S, Chung KY, Choi KY. The Dishevelled-binding protein CXXC5 negatively regulates cutaneous wound healing. J Exp Med. 2015 Jun 29;212(7):1061-80. doi: 10.1084\/jem.20141601. Epub 2015 Jun 8. PMID: 26056233; PMCID: PMC4493411.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.mdpi.com\/2073-4409\/12\/4\/555\"\u003eRyu, Y.C.; Park, J.; Kim, Y.-R.; Choi, S.; Kim, G.-U.; Kim, E.; Hwang, Y.; Kim, H.; Han, G.; Lee, S.-H.; et al. CXXC5 Mediates DHT-Induced Signaling via PGD2. Cells 2023, 12, 555. https:\/\/doi.org\/10.3390\/cells12040555\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/22506014\/\"\u003eLee SH, Yoon J, Shin SH, Zahoor M, Kim HJ, Park PJ, Park WS, Min do S, Kim HY, Choi KY. Valproic acid induces hair regeneration in murine model and activates alkaline phosphatase activity in human dermal papilla cells. PLoS One. 2012;7(4):e34152. doi: 10.1371\/journal.pone.0034152. Epub 2012 Apr 10. PMID: 22506014; PMCID: PMC3323655.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC10750333\/\"\u003eLiu D, Xu Q, Meng X, Liu X, Liu J. Status of research on the development and regeneration of hair follicles. Int J Med Sci. 2024 Jan 1;21(1):80-94. doi: 10.7150\/ijms.88508. PMID: 38164355; PMCID: PMC10750333.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/PTD-DBM.avif?v=1779874912\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/PTD-DBM.avif?v=1779874912\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"10mg","offer_id":53240042815788,"sku":"PEP-VIL-PTDDBM-10MG369652","price":94.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ptd-dbm-website-card-1747916617664.png?v=1779696850"},{"product_id":"ghk-cu-50mg-research-spray","title":"GHK-Cu - 50mg - Research Spray Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eGHK-Cu research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC14H21N6O4\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\t\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e89030-95-5\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e404.9 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eChemical Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC14H21CuN6O4\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eGly-His-Lys\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eCopper tripeptide-1, Copper-GHK, GHK-Cu, Copper peptide\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eBlue powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How Is GHK-Cu Used in Research?\" id=\"how-is-ghk-cu-used-in-research\"\u003eHow Is GHK-Cu Used in Research?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eGHK-Cu is associated with a range of biological pathways linked to cellular signaling and extracellular matrix dynamics. Its role has been explored in collagen-related processes, angiogenic signaling, and cellular activity within skin-associated cell types such as fibroblasts and keratinocytes. Additional work has focused on its relationship to oxidative stress and inflammatory signaling.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e \u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eAt the molecular level, its relationship to gene expression has been examined, particularly in processes tied to extracellular matrix turnover and cellular signaling. This includes matrix metalloproteinases (MMPs), which are associated with the breakdown and restructuring of proteins such as collagen and elastin.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e \u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eIn addition, scientists have studied GHK-Cu for its ability to bind copper ions, which play a role in enzymatic processes related to collagen structure and cross-linking, including those involving lysyl oxidase. These interactions are associated with broader structural and signaling functions within the extracellular matrix.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Areas of Study\" id=\"areas-of-study\"\u003eAreas of Study\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eSkin structure: GHK-Cu has drawn interest in relation to skin composition and extracellular matrix dynamics, including its connection to collagen-related activity and overall structural organization.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eTissue dynamics: Research has also looked at how GHK-Cu relates to cellular behavior tied to tissue organization, including aspects of cell movement, growth patterns, and structural coordination.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eOxidative activity: Scientific work in this area has examined GHK-Cu’s relationship to oxidative balance and cellular responses to environmental stressors.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eFollicular function: Additional attention has been given to GHK-Cu’s connection with hair follicle biology, including factors linked to growth cycle behavior and cellular activity within the follicle environment.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eNeural systems: Interest has also extended to GHK-Cu’s relationship with neural activity and cellular stress responses, particularly in areas tied to oxidative balance and protein regulation.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eGHK-Cu is a naturally occurring peptide complex that has attracted attention for its role in a variety of biological systems. Recent research highlights its connection to extracellular matrix dynamics, cellular activity, and oxidative balance, along with areas related to skin biology and structural organization.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e \u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eExisting findings offer insight into how this compound interacts within these systems, though its full range of biological activity is still being defined. Continued investigation will help clarify how these interactions vary across different experimental conditions.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e \u003c\/p\u003e\n\u003cp style=\"line-height:1.2;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:10pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eAs with any research material, appropriate handling practices and established laboratory guidelines should be followed. Ongoing scientific interest reflects GHK-Cu’s relevance as a tool for studying complex cellular and biochemical functions.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38394858\/\"\u003eWang Y, Lin J, Yu Z, Cheng J, Cheng J, Cui W. Rigid-flexible nanocarriers loaded with active peptides for antioxidant and anti-inflammatory applications in skin. Colloids Surf B Biointerfaces. 2024.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38345677\/\"\u003eRakhmetova KK, Mishina ES, Bobyntsev II, Bezhin AI, Vorvul AO. Effects of Gly-His-Lys-D-Ala Peptide on Skin Wound Regeneration Processes. Bull Exp Biol Med. 2024.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38045355\/\"\u003eTucker M, Liao GY, Park JY, Rosenfeld M, Wezeman J, Mangalindan R, Ratner D, Darvas M, Ladiges W. Behavioral and neuropathological features of Alzheimer's disease are attenuated in 5xFAD mice treated with intranasal GHK peptide. bioRxiv [Preprint]. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38026438\/\"\u003eLiu T, Liu Y, Zhao X, Zhang L, Wang W, Bai D, Liao Y, Wang Z, Wang M, Zhang J. Thermodynamically stable ionic liquid microemulsions pioneer pathways for topical delivery and peptide application. Bioact Mater. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38014118\/\"\u003eTucker M, Keely A, Park JY, Rosenfeld M, Wezeman J, Mangalindan R, Ratner D, Ladiges W. Intranasal GHK peptide enhances resilience to cognitive decline in aging mice. bioRxiv [Preprint]. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37257226\/\"\u003eZhang Q, Liu J, Deng MM, Tong R, Hou G. Relief of ovalbumin-induced airway remodeling by the glycyl-l-histidyl-l-lysine-Cu2+ tripeptide complex via activation of SIRT1 in airway epithelial cells. Biomed Pharmacother. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37381226\/\"\u003eRen Z, Liu C, Wei Y, Liu C, Shi C, Wang X, Tang Y, Wang R, Liu Z. Multi working mode SPR chip laboratory for high refractive index detection. Opt Express. 2023\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37180036\/\"\u003eWang F, Yu X, Yu Z, Cui Y, Xu L, Huo S, Ding Z, Zhao L, Du L, Qiu Y. Improved laccase production by Trametes versicolor using Copper-Glycyl-L-Histidyl-L-Lysine as a novel and high-efficient inducer. Front Bioeng Biotechnol. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37062921\/\"\u003eJiang F, Wu Y, Liu Z, Hong M, Huang Y. Synergy of GHK-Cu and hyaluronic acid on collagen IV upregulation via fibroblast and ex-vivo skin tests. J Cosmet Dermatol. 2023.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36905132\/\"\u003eDeng M, Zhang Q, Yan L, Bian Y, Li R, Gao J, Wang Y, Miao J, Li J, Zhou X, Hou G. Glycyl-l-histidyl-l-lysine-Cu2+ rescues cigarette smoking-induced skeletal muscle dysfunction via a sirtuin 1-dependent pathway. J Cachexia Sarcopenia Muscle. 2023\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GHK-Cu_-_50mg_-_Research_Spray_Kit-1.avif?v=1779874697\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GHK-Cu_-_50mg_-_Research_Spray_Kit-1.avif?v=1779874697\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GHK-Cu_-_50mg_-_Research_Spray_Kit-2.avif?v=1779874696\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GHK-Cu_-_50mg_-_Research_Spray_Kit-2.avif?v=1779874696\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GHK-Cu_-_50mg_-_Research_Spray_Kit-3.avif?v=1779874697\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/GHK-Cu_-_50mg_-_Research_Spray_Kit-3.avif?v=1779874697\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240042946860,"sku":"9635851350959","price":57.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ghk-cu-research-spray-kit-webpage-1763564793637.png?v=1779696854"},{"product_id":"tb-500-bpc-157-research-spray-kit","title":"BPC-157 + TB-500 5mg\/5mg (10mg\/7ml) Research Spray Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eMulti-peptide research blend. Multiple lyophilized peptide compounds supplied as a combined preparation for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for in vitro experimentation or analytical reference studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003cp\u003eMolecular Formula\u003c\/p\u003e\n\u003cp\u003eC98H144N28O32 (BPC-157), C212H350N56O78S (TB-500)\u003c\/p\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\tNumber\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e137525-51-0 (BPC-157), 77591-33-4 (TB-500)\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e2188.34 g\/mol (BPC-157), 4963.46 g\/mol (TB-500)\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eBPC-157: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val, TB-500: Ser-Asp-Lys-Pro-Asp-Met-Ala-Glu-Ile-Glu-Lys-Phe-Asp-Lys-Ser-Lys-Leu-Lys-Lys-Thr-Glu-Thr-Gln-Glu-Lys-Asn-Pro-Leu-Pro-Ser-Lys-Glu-Thr-Ile-Glu-Gln-Glu-Lys-Gln-Ala-Gly-Glu-Ser \u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eBody Protection Compound-157, Thymosin β-4\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWater-soluble\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite lyophilized powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eBlend of BPC-157 and TB-500 peptides\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How is BPC-157 and TB-500 blend used in research?\" id=\"how-is-bpc-157-and-tb-500-blend-used-in-research\"\u003eHow is BPC-157 and TB-500 blend used in research?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eBPC-157 and TB-500 each have unique mechanisms of action that contribute to their combined properties in laboratory research. BPC-157 has been examined for its impact on angiogenesis, collagen synthesis, and modulation of the nitric oxide (NO) system. It has also been shown to affect inflammatory mediators such as cytokines and free radicals.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eTB-500 is involved in regulating actin polymerization, a process relevant to cell migration in experimental models. It has also been investigated for its effects on keratinocyte and endothelial cell migration, as well as on inflammatory cytokines.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eWhen analyzed together in laboratory settings, BPC-157 and TB-500 can be used to explore potential synergistic influences on cellular behavior, angiogenesis, collagen production, and inflammatory pathways.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Areas of Study\" id=\"areas-of-study\"\u003eAreas of Study\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:12pt;\" dir=\"ltr\"\u003eThe BPC-157 and TB-500 blend is supplied for laboratory research purposes only. Researchers can use this peptide combination to explore its properties and effects in experimental models. Some areas of study include:\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"-webkit-text-decoration-skip:none;background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003eCellular behavior in wound models: The combination has been examined for its influence on cell migration, angiogenesis, and collagen synthesis in experimental wound models.\u003c\/li\u003e\n\u003cli style=\"-webkit-text-decoration-skip:none;background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003eTissue regeneration research: This blend may be used to study regenerative processes in various tissue types under laboratory conditions.\u003c\/li\u003e\n\u003cli style=\"-webkit-text-decoration-skip:none;background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003eInflammatory response modulation: Both peptides have been observed to affect cytokine activity and other markers of inflammation in experimental settings.\u003c\/li\u003e\n\u003cli style=\"-webkit-text-decoration-skip:none;background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003eNeuroscience research: BPC-157 has been investigated for potential effects on neuronal cells in laboratory studies.\u003c\/li\u003e\n\u003cli style=\"-webkit-text-decoration-skip:none;background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003eVascular studies: Researchers may examine angiogenesis and blood vessel formation in controlled experimental systems.\u003c\/li\u003e\n\u003cli style=\"-webkit-text-decoration-skip:none;background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration-skip-ink:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003eMusculoskeletal models: The peptide combination can be applied in research exploring cell migration, tissue remodeling, and other musculoskeletal processes in vitro or in vivo models.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eWe provide this BPC-157 + TB-500 Blend + Research Spray Kit specifically for research use; scientists and students may utilize it to analyze peptide stability, interactions, and delivery methods under structured research environments. With access to these peptide compounds, researchers will be able to evaluate both individual and blended peptide behaviors. And the spray tool allows for alternative administration routes and bioavailability comparisons. Supplied as a lyophilized, water-soluble powder, the blend requires reconstitution before use and should be handled with standard laboratory safety practices, including proper storage, sterile preparation, and disposal protocols.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003col\u003e\n\u003cli\u003e\u003cp\u003eChang, C. H., Tsai, W. C., Lin, M. S., Hsu, Y. H., \u0026amp; Pang, J. H. S. (2011). The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. Journal of Applied Physiology, 110(3), 774-780.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHuang, T., Zhang, K., Sun, L., Xue, X., Zhang, C., Shu, Z., ... \u0026amp; Pang, J. (2015). Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Design, Development and Therapy, 9, 2485.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/25995620\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eSikiric, P., Seiwerth, S., Rucman, R., Turkovic, B., Rokotov, D. S., Brcic, L., ... \u0026amp; Vlainic, J. (2014). Stable gastric pentadecapeptide BPC 157-NO-system relation. Current Pharmaceutical Design, 20(7), 1126-1135.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23755725\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/23755725\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003ePhilp, D., Kleinman, H. K., \u0026amp; Goldblatt, P. J. (2010). Thymosin β4 and the potential for therapeutic applications. Expert Opinion on Biological Therapy, 10(1), 149-158.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20001564\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/20001564\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eSosne, G., Qiu, P., Goldstein, A. L., \u0026amp; Wheater, M. (2010). Biological activities of thymosin β4 defined by active sites in short peptide sequences. The FASEB Journal, 24(7), 2144-2151.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/20179146\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/20179146\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eHsieh, M. J., Liu, H. T., Wang, C. N., Huang, H. Y., Lin, Y., Ko, Y. S., ... \u0026amp; Pang, J. H. S. (2017). Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine, 95(3), 323-333.\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27847966\/\"\u003e \u003cu\u003ehttps:\/\/pubmed.ncbi.nlm.nih.gov\/27847966\/\u003c\/u\u003e\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_TB-500_5mg5mg_10mg7ml_Research_Spray_Kit-1.avif?v=1779873579\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_TB-500_5mg5mg_10mg7ml_Research_Spray_Kit-1.avif?v=1779873579\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_TB-500_5mg5mg_10mg7ml_Research_Spray_Kit-2.avif?v=1779873580\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_TB-500_5mg5mg_10mg7ml_Research_Spray_Kit-2.avif?v=1779873580\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240043340076,"sku":"9635852746437","price":82.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/bpc157-tb500-research-spray-kit-webcard-_1_-1761573032309-1765966902640.png?v=1779696862"},{"product_id":"immune","title":"Complete Immunology Research Stack","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eMulti-peptide research bundle. Includes multiple lyophilized peptide reference compounds packaged together for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003eEach component is individually purity-tested. Intended for in vitro experimentation and analytical reference studies.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240043405612,"sku":"9635852615756","price":150.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image-_90_-1756736681831.png?v=1779696864"},{"product_id":"ara-290-research-kit","title":"ARA-290 Research Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eARA-290 research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cfigure class=\"table\"\u003e\u003ctable\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolecular Formula\u003c\/td\u003e\n\u003ctd\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eC512H84N16O21\u003c\/span\u003e\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCAS\u003c\/td\u003e\n\u003ctd\u003e\u003cspan style=\"background-color:#ffffff;color:#111827;font-family:Arial,sans-serif;font-size:12pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e1208243-50-8\u003c\/span\u003e\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMolar Mass\u003c\/td\u003e\n\u003ctd\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e1257.3 g\/mol\u003c\/span\u003e\u003c\/span\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eChemical Formula\u003c\/td\u003e\n\u003ctd\u003e C78H123N23O21S\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAmino Acid Sequence\u003c\/td\u003e\n\u003ctd\u003ePyr-Glu-Gln-Leu-Glu-Arg-Ala-Leu-Asn-Ser-Ser\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSynonyms\u003c\/td\u003e\n\u003ctd\u003ePyroglutamate Helix B Surface Peptide, pHBSP, ARA 290, Cibinetide\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSolubility\u003c\/td\u003e\n\u003ctd\u003eWater-soluble\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eOrganoleptic Profile\u003c\/td\u003e\n\u003ctd\u003eWhite to off-white powder\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eComposition\u003c\/td\u003e\n\u003ctd\u003eLyophilized powder - requires reconstitution\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\u003c\/table\u003e\u003c\/figure\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How is ARA-290 Used in Research?\" id=\"how-is-ara-290-used-in-research\"\u003eHow is ARA-290 Used in Research?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:0pt;margin-top:0pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eARA-290 is studied in laboratory and preclinical research as a model peptide for investigating molecular and cellular pathways. Typical research applications include:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eReceptor interaction assays:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Testing peptide binding to erythropoietin-related receptors under controlled lab conditions.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eSignal transduction studies\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e: Monitoring intracellular pathways triggered by peptide–receptor engagement.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePeptide delivery evaluations:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Using the spray kit to compare dispersion, solution stability, and administration techniques.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eMolecular pathway modeling\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e: Investigating how the peptide influences metabolic, neural, and inflammatory signaling in vitro or in vivo models.\u003c\/span\u003e\u003c\/span\u003e\u003cbr\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Areas of Study\" id=\"areas-of-study\"\u003eAreas of Study\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:12pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eARA-290 research spans multiple scientific disciplines:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eNeurobiology:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory investigations into peptide activity in neural signaling and experimental neuropathy models.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eMetabolic research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Studies modeling molecular pathways involved in energy regulation and metabolic signaling.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eInflammatory pathway research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Experimental studies exploring interactions with oxidative and inflammatory mechanisms.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eCardiovascular research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory studies examining peptide interactions with vascular signaling pathways, endothelial cell behavior, and tissue-level inflammatory mechanisms in experimental models.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eRenal research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Experimental investigations into molecular pathways in kidney cells and tissue models.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eCell survival and cytoprotection studies:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Research exploring peptide effects on cellular resilience, stress responses, and tissue-level signaling in controlled experimental systems.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePain and neuropathic pathway research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Mechanistic studies on sensory neuron signaling and molecular pathways involved in experimental neuropathic models.\u003c\/span\u003e\u003c\/span\u003e\u003cspan style=\"background-color:transparent;color:hsl(0,0%,100%);font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003esignaling in controlled experimental systems.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cspan style=\"background-color:transparent;color:hsl(0,0%,100%);font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePain and neuropathic pathway research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Mechanistic studies on sensory neuron signaling and molecular pathways involved in experimental neuropathic models.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eThe ARA-290 Research Spray Kit contains a synthetic, nonerythropoietic peptide supplied with a precision spray applicator for controlled laboratory investigations. It supports studies into peptide–receptor interactions, signal transduction pathways, and comparative administration models. Designed strictly for research use, the kit enables experiments on molecular, metabolic, neural, and inflammatory pathways while providing a reliable system for evaluating peptide dispersion and solution stability.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24555851\/\"\u003evan Velzen M, Heij L, Niesters M, Cerami A, Dunne A, Dahan A, Brines M. ARA 290 for treatment of small fiber neuropathy in sarcoidosis. Expert Opin Investig Drugs. 2014\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26774587\/\"\u003eZhang W, Yu G, Zhang M. ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception. Peptides. 2016\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34343617\/\"\u003eAl-Onaizi MA, Thériault P, Lecordier S, Prefontaine P, Rivest S, ElAli A. Early monocyte modulation by the non-erythropoietic peptide ARA 290 decelerates AD-like pathology progression. Brain Behav Immun. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25387363\/\"\u003eBrines M, Dunne AN, van Velzen M, Proto PL, Ostenson CG, Kirk RI, Petropoulos IN, Javed S, Malik RA, Cerami A, Dahan A. ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes. Mol Med. 2015\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26683514\/\"\u003eWatanabe M, Lundgren T, Saito Y, Cerami A, Brines M, Östenson CG, Kumagai-Braesch M. A Nonhematopoietic Erythropoietin Analogue, ARA 290, Inhibits Macrophage Activation and Prevents Damage to Transplanted Islets. Transplantation. 2016\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35317117\/\"\u003eMohtavinejad N, Hajiramezanali M, Akhlaghi M, Bitarafan-Rajabi A, Gholipour N. Synthesis and evaluation of 99mTc-DOTA-ARA-290 as potential SPECT tracer for targeting cardiac ischemic region. Iran J Basic Med Sci. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24136731\/\"\u003eDahan A, Dunne A, Swartjes M, Proto PL, Heij L, Vogels O, van Velzen M, Sarton E, Niesters M, Tannemaat MR, Cerami A, Brines M. ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density. Mol Med. 2013\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/27507833\/\"\u003eAtkins C, Wilson AM. Managing fatigue in sarcoidosis - A systematic review of the evidence. Chron Respir Dis. 2017\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24603865\/\"\u003eLiu Y, Luo B, Han F, Li X, Xiong J, Jiang M, Yang X, Wu Y, Zhang Z. Erythropoietin-derived nonerythropoietic peptide ameliorates experimental autoimmune neuritis by inflammation suppression and tissue protection. PLoS One. 2014\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36741836\/\"\u003eWinicki NM, Nanavati AP, Morrell CH, Moen JM, Axsom JE, Krawczyk M, Petrashevskaya NN, Beyman MG, Ramirez C, Alfaras I, Mitchell SJ, Juhaszova M, Riordon DR, Wang M, Zhang J, Cerami A, Brines M, Sollott SJ, de Cabo R, Lakatta EG. A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan. Front Cardiovasc Med. 2023\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ARA-290_Research_Kit.avif?v=1779873222\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ARA-290_Research_Kit.avif?v=1779873222\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240043733292,"sku":"9635853170045","price":58.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/ara-290-research-spray-kit-1763134888825.png?v=1779696868"},{"product_id":"bpc-157-5mg-research-spray","title":"BPC-157 - 5mg - Research Spray Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eBPC-157 research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC62H98N16O22\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\t\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e137525-51-0\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e773.895 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eGVSWGLR\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eBpc-157, 137525-51-0, Bpc 157, Bepecin Bpc 15, Bpc157, Body protection compound 15\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eSoluble in Water\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How does BPC-157 work?\" id=\"how-does-bpc-157-work\"\u003eHow does BPC-157 work?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp\u003eBPC-157 is believed to work through several mechanisms to support healing and tissue regeneration. One of its primary actions is promoting angiogenesis, the formation of new blood vessels. This increased blood flow can help deliver oxygen and nutrients to damaged tissues, facilitating repair and regeneration. BPC-157 has also been shown to stimulate the production of collagen, a key protein in connective tissues such as tendons and ligaments.\u003c\/p\u003e\n\u003cp\u003eAdditionally, BPC-157 may have anti-inflammatory properties, helping to reduce inflammation and oxidative stress in various tissues. This can create a more favorable environment for healing and may help alleviate pain associated with injuries or inflammatory conditions.\u003c\/p\u003e\n\u003cp\u003eBPC-157 has also demonstrated neuroprotective effects, potentially helping to protect and regenerate nerve cells. This may be beneficial in conditions involving nerve damage or degeneration.\u003c\/p\u003e\n\u003cp\u003eFurthermore, BPC-157 has been shown to interact with the nitric oxide (NO) system, which plays a role in various physiological processes, including blood vessel dilation and tissue repair. By modulating the NO system, BPC-157 may help regulate blood flow and support healing processes.\u003c\/p\u003e\n\u003cp\u003eWhile the exact mechanisms of action are still being researched, BPC-157's potential to promote angiogenesis, collagen production, and tissue regeneration, along with its anti-inflammatory and neuroprotective properties, may contribute to its therapeutic potential.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Benefits\" id=\"benefits\"\u003eBenefits\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul\u003e\n\u003cli\u003e\u003cp\u003eBPC-157 has been studied for its potential benefits in various health conditions. It may help accelerate wound healing, promote tissue regeneration, and support the repair of tendons, ligaments, and muscles. BPC-157 has shown promise in the treatment of inflammatory bowel disease, potentially reducing inflammation and promoting healing in the gut.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eIn animal studies, BPC-157 has demonstrated potential benefits in treating joint and tendon injuries, such as tendinitis and osteoarthritis. It may also have neuroprotective properties, which could be beneficial in conditions involving nerve damage or degeneration.\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003eAdditionally, BPC-157's potential anti-inflammatory and antioxidant effects may help reduce oxidative stress and inflammation in various tissues, supporting overall health and recovery from injuries or chronic conditions.\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Side Effects\" id=\"side-effects\"\u003eSide Effects\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eIn animal studies, BPC-157 has been well-tolerated with no reported severe side effects. However, as with any substance, individual responses may vary. More research is needed to fully understand the potential side effects of BPC-157 in mammals, including long-term safety.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003eBPC-157 is a promising synthetic peptide derived from a protein found in gastric juice. Research has shown its potential to support healing processes, promote tissue regeneration, and reduce inflammation in various tissues. BPC-157 may work by stimulating angiogenesis, collagen production, and modulating the nitric oxide system. It has been studied for its potential benefits in treating conditions such as inflammatory bowel disease, joint and tendon injuries, and skin wounds. Additionally, BPC-157 has demonstrated neuroprotective properties and may help reduce oxidative stress. While more research is needed to fully understand its mechanisms of action and long-term safety in mammals, BPC-157 continues to be a subject of interest for its potential therapeutic applications.\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2021.718147\/full\"\u003eVukojevic, Katarina et al. \"Stable gastric pentadecapeptide BPC 157 and wound healing.\" Frontiers in pharmacology vol. 12 718147\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34267654\/\"\u003eGwyer, Danielle et al. \"Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing.\" Cell and tissue research vol. 383,3 (2021)\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36551977\/\"\u003eKalogjera, Livije et al. \"Stable Gastric Pentadecapeptide BPC 157 in the Therapy of the Nasal Mucosa, Periodontium, and Dry Eye Syndrome.\" Biomedicines vol. 10,12 3281. 7 Dec. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/31158953\/\"\u003eSikiric, Predrag et al. \"Brain-gut Axis and Pentadecapeptide BPC 157: Theoretical and Practical Implications.\" Current neuropharmacology vol. 17,11 (2019)\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35449779\/\"\u003eKnezevic, Maro et al. \"Stable Gastric Pentadecapeptide BPC 157 Therapy for Periodontitis in Rats.\" Biomedicines vol. 10,4 859. 6 Apr. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35125818\/\"\u003eKokot, Antonio et al. \"Stable Gastric Pentadecapeptide BPC 157 Therapy for Primary Abdominal Compartment Syndrome in Rats.\" Frontiers in pharmacology vol. 13 861711. 18 Feb. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/35052769\/\"\u003eKnezevic, Maro et al. \"Stable Gastric Pentadecapeptide BPC 157 and Periodontal Healing in Rats.\" Biomedicines vol. 10,2 265. 25 Jan. 2022\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34203464\/\"\u003eSever, Marko et al. \"Stable Gastric Pentadecapeptide BPC 157 Therapy for Periodontitis in Rats.\" Biomedicines vol. 9,7 774. 29 Jun. 2021\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32547687\/\"\u003eSikiric, Predrag et al. \"Stable Gastric Pentadecapeptide BPC 157-NO-system Relation.\" Current pharmaceutical design vol. 26,25 (2020)\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/21030672\/#:~:text=In%20conclusion%2C%20BPC%20157%20promotes,of%20the%20FAK%2Dpaxillin%20pathway.\"\u003eChang CH, Tsai WC, Lin MS, Hsu YH, Pang JH. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J Appl Physiol (1985). 2011 Mar;110(3):774-80. doi: 10.1152\/japplphysiol.00945.2010. Epub 2010 Oct 28. PMID: 21030672\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_-_5mg_-_Research_Spray_Kit.avif?v=1779872928\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/BPC-157_-_5mg_-_Research_Spray_Kit.avif?v=1779872928\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240043798828,"sku":"9635853487758","price":52.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/image---2025-09-09t130830.714-1763561762339.png?v=1779696870"},{"product_id":"5-amino-1mq-research-kit","title":"5-Amino-1MQ Research Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003e5-Amino-1MQ research kit. Includes a lyophilized peptide vial and accessory components for laboratory research preparation.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot. Intended for compound characterization, reference experiments, or laboratory training applications.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eC10H11N2+\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\t\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e42464-96-0\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e 152.21 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eNot a peptide sequence but a small molecule NNMT inhibitor\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e5-Amino-1-MQ iodide, 5-Amino-1-methylquinolinium, iodide (1:1), 5-Amino-1MQ iodide\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eSoluble in Water\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003ePowder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How is 5-Amino-1MQ Used in Research?\" id=\"how-is-5-amino-1mq-used-in-research\"\u003eHow is 5-Amino-1MQ Used in Research?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:12pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e5-Amino-1MQ is studied in laboratory and preclinical research as a tool to investigate NNMT activity and its influence on metabolic and cellular pathways. Typical research applications include:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eEnzyme inhibition studies:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Measuring NNMT activity and the effects of 5-Amino-1MQ on methylation pathways.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eMetabolic pathway modeling:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Evaluating the compound’s impact on NAD+ metabolism, energy regulation, and related molecular pathways.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eDelivery evaluations:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Using the spray kit to compare absorption efficiency, solution stability, and alternative administration routes.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eCellular assays:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Investigating effects on cellular metabolism, mitochondrial function, and experimental metabolic models.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Areas of Study\" id=\"areas-of-study\"\u003eAreas of Study\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eMetabolic research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Examining NNMT activity and its modulation in cell and tissue models.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eCellular energy regulation:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Studying effects on NAD+ turnover, mitochondrial respiration, and metabolic signaling.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eObesity and adipose tissue models:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Experimental studies modeling NNMT’s role in fat metabolism and energy homeostasis.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eLiver and kidney metabolism:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Investigating molecular pathways in hepatic and renal cells under controlled conditions.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePreclinical pharmacology:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory research exploring compound stability, enzyme interactions, and downstream signaling.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eThe 5-Amino-1MQ Research Spray Kit contains a selective NNMT inhibitor supplied as a lyophilized powder with a precision spray system for controlled laboratory use. The kit allows for evaluation of multiple administration routes, absorption efficiency, and solution stability while supporting research into metabolic regulation, cellular energy pathways, and enzyme activity. This product is intended exclusively for research use.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/29155147\/\"\u003eNeelakantan H, Vance V, Wetzel MD, Wang HY, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochem Pharmacol. 2018 Jul;154:161-171. doi: 10.1016\/j.bcp.2018.05.003. Epub 2018 May 5. PMID: 29738706; PMCID: PMC6015571.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/25596852\/\"\u003eKannt A, Pfenninger A, Teichert L, Tönjes A, Dietrich A, Schön MR, Klöting N, Blüher M. Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance. Diabetologia. 2015 Apr;58(4):799-808. doi: 10.1007\/s00125-014-3490-7. Epub 2015 Jan 18. PMID: 25596852; PMCID: PMC4351435.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/24717514\/\"\u003eKraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014 Apr 10;508(7495):258-62. doi: 10.1038\/nature13198. PMID: 24717514; PMCID: PMC4107212.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/23455543\/\"\u003eUlanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol. 2013 May;9(5):300-6. doi: 10.1038\/nchembio.1204. Epub 2013 Mar 3. PMID: 23455543; PMCID: PMC3631284.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003cli\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/26168293\/\"\u003eHong S, Moreno-Navarrete JM, Wei X, Kikukawa Y, Tzameli I, Prasad D, Lee Y, Asara JM, Fernandez-Real JM, Maratos-Flier E, Pissios P. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat Med. 2015 Aug;21(8):887-94. doi: 10.1038\/nm.3882. Epub 2015 Jul 13. PMID: 26168293; PMCID: PMC4529375.\u003c\/a\u003e\u003c\/p\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/5-Amino-1MQ_Research_Kit.avif?v=1779871332\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/5-Amino-1MQ_Research_Kit.avif?v=1779871332\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \n    \u003c\/div\u003e\n\t\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240043929900,"sku":"9635853107484","price":93.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/5-amino-1mq-research-spray-kit-1763559708952.png?v=1779696873"},{"product_id":"cagrilintide-10mg-research-spray","title":"Cagrilintide - 10mg - Research Spray Kit","description":"\u003cdiv class=\"strapi-description text-sm text-[#4B5563] md:text-base line-clamp-6\"\u003e\n\u003cp\u003eCagrilintide research compound. Supplied as a lyophilized peptide for laboratory research applications.\u003c\/p\u003e\n\u003cp\u003ePurity-tested per lot.\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eFor laboratory research use only. Not for human or veterinary use.\u003c\/strong\u003e\u003c\/p\u003e\n\u003c\/div\u003e\u003cdiv class=\"container px-3\"\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Characteristics\" id=\"characteristics\"\u003eCharacteristics\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003ctable\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolecular Formula\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e\u003ca href=\"https:\/\/pubchem.ncbi.nlm.nih.gov\/#query=C194H312N54O59S2\"\u003eC194H312N54O59S2\u003c\/a\u003e\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eCAS\t\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e1415456-99-3\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eMolar Mass\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003e4409 g\/mol\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eAmino Acid Sequence\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLys-Cys-Asn-Thr-Ala-Thr-Cys-Ala-Thr-Gln-Arg-Leu-Ala-Glu-Phe-Leu-Arg-His-Ser-Ser-Asn-Asn-Phe-Gly-Pro-Ile-Leu-Pro-Pro-Thr-Asn-Val-Gly-Ser-Asn-Thr-Pro-NH2\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSynonyms\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eAM833, NN9838, long-acting amylin analog (LAAA), amylin receptor agonist, modified human amylin analog, acylated amylin analog, investigational amylin mimetic\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eSolubility\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eSoluble in Water\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eOrganoleptic Profile\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eWhite powder\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003e\u003cp\u003eComposition\u003c\/p\u003e\u003c\/td\u003e\n\u003ctd\u003e\u003cp\u003eLyophilized powder - requires reconstitution\u003c\/p\u003e\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/table\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"How is Cagrilintide Used in Research?\" id=\"how-is-cagrilintide-used-in-research\"\u003eHow is Cagrilintide Used in Research?\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003cp style=\"line-height:1.38;margin-bottom:12pt;margin-top:12pt;\" dir=\"ltr\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eResearchers employ Cagrilintide in laboratory models to investigate its molecular interactions and behavior under controlled conditions:\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eIn vitro assays:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Biochemical and cell culture experiments to study peptide stability, receptor binding, and molecular interactions.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eIn vivo models:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Animal-based studies designed to explore peptide activity in whole biological systems.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePharmacokinetic-style evaluations:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory setups assessing absorption, dispersion, and peptide stability in solution.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eFormulation and delivery testing:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Comparative studies using the spray system to evaluate alternative administration methods and bioavailability.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Areas of Study\" id=\"areas-of-study\"\u003eAreas of Study\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cul style=\"margin-bottom:0;margin-top:0;padding-inline-start:48px;\"\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eMetabolic signaling research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory investigations into peptide interactions with receptors in controlled metabolic models.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eEndocrinology models:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Experimental studies on peptide behavior in hormone-related laboratory systems.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eObesity and metabolic regulation studies:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Research using controlled models to examine pathways related to energy balance and receptor activity.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003eMolecular biology applications:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Studies examining peptide-protein interactions, receptor binding, and signaling mechanisms.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003cli style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;font-style:normal;font-variant:normal;font-weight:400;list-style-type:disc;text-decoration:none;vertical-align:baseline;white-space:pre;\" dir=\"ltr\" aria-level=\"1\"\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e\u003cstrong\u003ePharmacological research:\u003c\/strong\u003e\u003c\/span\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003e Laboratory analyses of peptide stability, dispersion, and solution behavior using spray-based delivery.\u003c\/span\u003e\u003c\/span\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"Summary\" id=\"summary\"\u003eSummary\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\u003cp\u003e\u003cspan style=\"background-color:transparent;color:#000000;font-family:Arial,sans-serif;font-size:11pt;\"\u003e\u003cspan style=\"font-style:normal;font-variant:normal;font-weight:400;text-decoration:none;vertical-align:baseline;white-space:pre-wrap;\"\u003eThe Cagrilintide 10mg Research Spray Kit provides a lyophilized peptide for controlled laboratory investigation. Its precision spray delivery system enables the study of alternative administration pathways, solution stability, and absorption efficiency. The kit supports a range of experimental studies, including metabolic signaling, endocrinology, molecular biology, and pharmacological research.\u003c\/span\u003e\u003c\/span\u003e\u003c\/p\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" data-scroll-name=\"References\" id=\"references\"\u003eReferences\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"strapi-content max-w-none text-[#4B5563]\"\u003e\n\u003col\u003e\n\u003cli\u003e\u003ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/33894838\/\"\u003e\u003cu\u003eEnebo LB, Berthelsen KK, Kankam M, Lund MT, Rubino DM, Satylganova A, Lau DCW. Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2·4 mg for weight management: a randomised, controlled, phase 1b trial. Lancet. 2021 May 8;397(10286):1736-1748. doi: 10.1016\/S0140-6736(21)00845-X. Epub 2021 Apr 22. PMID: 33894838.\u003c\/u\u003e\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34798060\/\"\u003e\u003cu\u003eLau DCW, Erichsen L, Francisco AM, Satylganova A, le Roux CW, McGowan B, Pedersen SD, Pietiläinen KH, Rubino D, Batterham RL. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial. Lancet. 2021 Dec 11;398(10317):2160-2172. doi: 10.1016\/S0140-6736(21)01751-7. Epub 2021 Nov 16. PMID: 34798060.\u003c\/u\u003e\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37364590\/\"\u003e\u003cu\u003eFrias JP, Deenadayalan S, Erichsen L, Knop FK, Lingvay I, Macura S, Mathieu C, Pedersen SD, Davies M. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial. Lancet. 2023 Aug 26;402(10403):720-730. doi: 10.1016\/S0140-6736(23)01163-7. Epub 2023 Jun 23. PMID: 37364590.\u003c\/u\u003e\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/www.sciencedirect.com\/science\/article\/abs\/pii\/S0014299922006586\"\u003e\u003cu\u003eSimone A. Melander, Anna Katri, Morten A. Karsdal, Kim Henriksen, Improved metabolic efficacy of a dual amylin and calcitonin receptor agonist when combined with semaglutide or empagliflozin, European Journal of Pharmacology, Volume 938, 2023, 175397, ISSN 0014-2999, https:\/\/doi.org\/10.1016\/j.ejphar.2022.175397.\u003c\/u\u003e\u003c\/a\u003e\u003c\/li\u003e\n\u003cli\u003e\u003ca target=\"_blank\" rel=\"noopener noreferrer\" href=\"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.jmedchem.5b00726\"\u003e\u003cu\u003eLau J, Bloch P, Schäffer L, et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. Journal of Medicinal Chemistry. 2015 Sep;58(18):7370-7380. DOI: 10.1021\/acs.jmedchem.5b00726. PMID: 26308095.\u003c\/u\u003e\u003c\/a\u003e\u003c\/li\u003e\n\u003c\/ol\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c!--$!--\u003e\u003ctemplate data-dgst=\"BAILOUT_TO_CLIENT_SIDE_RENDERING\"\u003e\u003c\/template\u003e\n  \u003cdiv data-scroll-name=\"Certificate of Analysis (COA)\" class=\"\"\u003e\n  \u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\n    \u003ch2 class=\"mb-6 text-2xl font-semibold leading-[2.25rem] tracking-tight md:my-0\" id=\"certificates\"\u003e\n      Certificate of Analysis (COA)\n    \u003c\/h2\u003e\n  \u003c\/div\u003e\n\n  \u003cdiv class=\"flex w-full flex-row flex-wrap gap-x-0 gap-y-4 md:gap-x-8\"\u003e\n  \n    \u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n\t\t\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Cagrilintide_-_10mg_-_Research_Spray_Kit.avif?v=1779870073\" target=\"_blank\"\u003e\n        \u003cimg alt=\"Certificate\" loading=\"lazy\" width=\"175\" height=\"227\" decoding=\"async\" data-nimg=\"1\" class=\"h-full w-full max-w-[150px] cursor-pointer rounded-none object-cover md:max-w-[175px]\" src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/Cagrilintide_-_10mg_-_Research_Spray_Kit.avif?v=1779870073\" style=\"color: transparent;\"\u003e\n\t\t\u003c\/a\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n\t\u003cdiv class=\"w-1\/2 md:w-fit\"\u003e\n      \u003cdiv class=\"relative overflow-hidden rounded-none\"\u003e\n      \u003c\/div\u003e\n    \u003c\/div\u003e\n\t\n  \u003c\/div\u003e\n\u003c\/div\u003e\n  \u003c!--\/$--\u003e\u003cdiv data-scroll-name=\"Resource\" class=\"\"\u003e\n\u003cdiv class=\"md:w-[30%] md:min-w-[30%]\"\u003e\u003ch2 class=\"mb-4 scroll-mt-20 text-2xl font-semibold leading-[2rem] tracking-tight md:scroll-mt-24\" id=\"resources\"\u003eResource\u003c\/h2\u003e\u003c\/div\u003e\n\u003cdiv class=\"w-full\"\u003e\u003cdiv class=\"text-base text-[#4B5563]\"\u003e\u003cspan\u003eAll products on this site are for research and development use only. Products are not for human consumption of any kind. The statements made on this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure, or prevent any disease. Power Peptides is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic Act. Power Peptides is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act. All products are sold for research, laboratory, or analytical purposes only, and are not for human consumption. Power Peptides Products are intended strictly for research purposes only. These products are not approved by the U.S. Food and Drug Administration (FDA) for human consumption or medical use. Under no circumstances should these peptides be used for any purpose other than research. By purchasing or using our peptides, you acknowledge and agree that you will use them solely in accordance with applicable laws and regulations and that you accept full responsibility for their use. Statements made on this website have not been evaluated by the USA Food and Drug Administration.\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"My Store","offers":[{"title":"Bundle","offer_id":53240044028204,"sku":"9635853499688","price":132.99,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0971\/5731\/6908\/files\/cagrilintide-research-spray-kit-1763562262878.png?v=1779696874"}],"url":"https:\/\/www.powerpieeptidesus.com\/collections\/new-arrivals.oembed?page=2","provider":"Power Peptides","version":"1.0","type":"link"}